false --12-31 Q2 0001308027 GA No No http://fasb.org/us-gaap/2023#OperatingLeaseLiability http://fasb.org/us-gaap/2023#FinanceLeaseLiability 0001308027 2023-01-01 2023-06-30 0001308027 2023-10-26 0001308027 2023-06-30 0001308027 2022-12-31 0001308027 us-gaap:RelatedPartyMember 2023-06-30 0001308027 us-gaap:RelatedPartyMember 2022-12-31 0001308027 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001308027 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001308027 us-gaap:SeriesBPreferredStockMember 2023-06-30 0001308027 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001308027 us-gaap:SeriesCPreferredStockMember 2023-06-30 0001308027 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001308027 2023-04-01 2023-06-30 0001308027 2022-04-01 2022-06-30 0001308027 2022-01-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-12-31 0001308027 us-gaap:CommonStockMember 2022-12-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001308027 us-gaap:RetainedEarningsMember 2022-12-31 0001308027 us-gaap:TreasuryStockCommonMember 2022-12-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-12-31 0001308027 us-gaap:NoncontrollingInterestMember 2022-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-03-31 0001308027 us-gaap:CommonStockMember 2023-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001308027 us-gaap:RetainedEarningsMember 2023-03-31 0001308027 us-gaap:TreasuryStockCommonMember 2023-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2023-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2023-03-31 0001308027 2023-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0001308027 us-gaap:CommonStockMember 2021-12-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001308027 us-gaap:RetainedEarningsMember 2021-12-31 0001308027 us-gaap:TreasuryStockCommonMember 2021-12-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2021-12-31 0001308027 us-gaap:NoncontrollingInterestMember 2021-12-31 0001308027 2021-12-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-03-31 0001308027 us-gaap:CommonStockMember 2022-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001308027 us-gaap:RetainedEarningsMember 2022-03-31 0001308027 us-gaap:TreasuryStockCommonMember 2022-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2022-03-31 0001308027 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-01-01 2023-03-31 0001308027 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001308027 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001308027 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2023-01-01 2023-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001308027 2023-01-01 2023-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-04-01 2023-06-30 0001308027 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001308027 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001308027 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2023-04-01 2023-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001308027 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001308027 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-01-01 2022-03-31 0001308027 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001308027 2022-01-01 2022-03-31 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001308027 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001308027 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-04-01 2022-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2023-06-30 0001308027 us-gaap:CommonStockMember 2023-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001308027 us-gaap:RetainedEarningsMember 2023-06-30 0001308027 us-gaap:TreasuryStockCommonMember 2023-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2023-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2023-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0001308027 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-06-30 0001308027 us-gaap:CommonStockMember 2022-06-30 0001308027 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001308027 us-gaap:RetainedEarningsMember 2022-06-30 0001308027 us-gaap:TreasuryStockCommonMember 2022-06-30 0001308027 VYST:TotalVystarStockholdersDeficitMember 2022-06-30 0001308027 us-gaap:NoncontrollingInterestMember 2022-06-30 0001308027 2022-06-30 0001308027 srt:MinimumMember 2023-06-30 0001308027 srt:MaximumMember 2023-06-30 0001308027 VYST:OptionsToPurchaseCommonSharesMember 2023-01-01 2023-06-30 0001308027 VYST:OptionsToPurchaseCommonSharesMember 2022-01-01 2022-06-30 0001308027 VYST:WarrantsToPurchaseCommonSharesMember 2023-01-01 2023-06-30 0001308027 VYST:WarrantsToPurchaseCommonSharesMember 2022-01-01 2022-06-30 0001308027 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-06-30 0001308027 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-06-30 0001308027 2022-01-01 2022-12-31 0001308027 VYST:ToolingAndTestingEquipmentMember 2023-06-30 0001308027 VYST:ToolingAndTestingEquipmentMember 2022-12-31 0001308027 VYST:FurnitureFixturesAndEquipmentMember 2023-06-30 0001308027 VYST:FurnitureFixturesAndEquipmentMember 2022-12-31 0001308027 us-gaap:PatentsMember 2023-06-30 0001308027 us-gaap:PatentsMember 2022-12-31 0001308027 srt:MinimumMember us-gaap:PatentsMember 2023-06-30 0001308027 srt:MaximumMember us-gaap:PatentsMember 2023-06-30 0001308027 VYST:ProprietaryTechnologyMember 2023-06-30 0001308027 VYST:ProprietaryTechnologyMember 2022-12-31 0001308027 VYST:TradeNameandBrandMember 2023-06-30 0001308027 VYST:TradeNameandBrandMember 2022-12-31 0001308027 srt:MinimumMember VYST:TradeNameandBrandMember 2023-06-30 0001308027 srt:MaximumMember VYST:TradeNameandBrandMember 2023-06-30 0001308027 srt:MinimumMember 2023-01-01 2023-06-30 0001308027 srt:MaximumMember 2023-01-01 2023-06-30 0001308027 VYST:OtherVendorsMember VYST:FidelityBankMember 2020-05-29 0001308027 VYST:ConvertiblePromissoryNotesMember 2021-12-31 0001308027 VYST:ConvertiblePromissoryNotesMember 2023-01-01 2023-06-30 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2018-12-31 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2018-01-01 2018-12-31 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2023-06-30 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2022-12-31 0001308027 VYST:ContingentlyConvertibleNotesPayableMember 2020-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesFiveMember VYST:JamieRotmanMember 2021-08-17 0001308027 VYST:RotmanFamilyConvertibleNotesFiveMember 2021-08-17 0001308027 VYST:RotmanFamilyConvertibleNotesFiveMember 2021-08-16 2021-08-17 0001308027 VYST:RotmanFamilyConvertibleNotesFiveMember VYST:JamieRotmanMember 2023-06-30 0001308027 VYST:RotmanFamilyConvertibleNotesFiveMember VYST:JamieRotmanMember 2022-12-31 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:RotmansMember 2023-06-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BernardRotmanMember 2023-06-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BernardRotmanMember 2023-01-01 2023-06-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember 2023-06-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember 2022-12-31 0001308027 VYST:BlueOarConsultingIncMember 2022-04-01 2022-04-30 0001308027 VYST:BlueOarConsultingIncMember us-gaap:RelatedPartyMember 2022-04-30 0001308027 VYST:BlueOarConsultingIncMember 2022-04-30 0001308027 VYST:BlueOarConsultingMember 2023-06-30 0001308027 VYST:BlueOarConsultingMember 2022-12-31 0001308027 VYST:RotmanFamilyConvertibleNotesMember 2023-01-01 2023-06-30 0001308027 VYST:RotmanFamilyNonConvertibleNotesMember 2023-01-01 2023-06-30 0001308027 VYST:RotmanFamilyConvertibleNoteMember 2023-06-30 0001308027 VYST:RotmanFamilyConvertibleNoteMember 2022-12-31 0001308027 VYST:RotmanFamilyNonConvertibleNoteMember 2023-06-30 0001308027 VYST:RotmanFamilyNonConvertibleNoteMember 2022-12-31 0001308027 VYST:JamieRotmanMember VYST:RotmanFamilyConvertibleNotesFiveMember 2023-01-01 2023-06-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BernardRotmanMember 2023-06-30 0001308027 VYST:RotmanFamilyNonconvertibleNotesOneMember VYST:BernardRotmanMember 2022-12-31 0001308027 VYST:BernardRotmanMember VYST:RotmanFamilyNonconvertibleNotesOneMember 2023-01-01 2023-06-30 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2013-05-01 2013-05-02 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:SeriesACumulativeConvertiblePreferredStockMember 2013-05-01 2013-05-02 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember 2013-05-01 2013-05-02 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember 2013-05-02 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:HolderMember 2023-06-30 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:HolderMember 2023-01-01 2023-06-30 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:HolderMember 2022-12-31 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:HolderMember 2022-01-01 2022-12-31 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:SeriesBCumulativeConvertiblePreferredStockMember 2022-04-10 2022-04-11 0001308027 VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-04-11 0001308027 VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-04-10 2022-04-11 0001308027 VYST:HolderMember VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2023-06-30 0001308027 VYST:HolderMember VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2023-01-01 2023-06-30 0001308027 VYST:HolderMember VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-12-31 0001308027 VYST:HolderMember VYST:TenPercentageSeriesBCumulativeConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001308027 VYST:TenPercentageSeriesACumulativeConvertiblePreferredStockMember VYST:SeriesCCumulativeConvertiblePreferredStockMember 2022-07-07 2022-07-08 0001308027 VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-07-08 0001308027 VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-07-07 2022-07-08 0001308027 VYST:HolderMember VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2023-06-30 0001308027 VYST:HolderMember VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2023-01-01 2023-06-30 0001308027 VYST:HolderMember VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-12-31 0001308027 VYST:HolderMember VYST:TenPercentageSeriesCCumulativeConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001308027 VYST:StockSubscriptionAgreementMember 2023-06-30 0001308027 VYST:StockSubscriptionAgreementMember 2022-12-31 0001308027 VYST:StockSubscriptionAgreementMember 2020-01-01 2020-12-31 0001308027 VYST:AirPurificationUnitsMember 2023-04-01 2023-06-30 0001308027 VYST:AirPurificationUnitsMember 2022-04-01 2022-06-30 0001308027 VYST:AirPurificationUnitsMember 2023-01-01 2023-06-30 0001308027 VYST:AirPurificationUnitsMember 2022-01-01 2022-06-30 0001308027 VYST:MattressesAndToppersMember 2023-04-01 2023-06-30 0001308027 VYST:MattressesAndToppersMember 2022-04-01 2022-06-30 0001308027 VYST:MattressesAndToppersMember 2023-01-01 2023-06-30 0001308027 VYST:MattressesAndToppersMember 2022-01-01 2022-06-30 0001308027 VYST:OtherMember 2023-04-01 2023-06-30 0001308027 VYST:OtherMember 2022-04-01 2022-06-30 0001308027 VYST:OtherMember 2023-01-01 2023-06-30 0001308027 VYST:OtherMember 2022-01-01 2022-06-30 0001308027 VYST:EmployeeAndBoardMembersMember 2022-01-01 2022-06-30 0001308027 VYST:StockOptionPlanMember 2004-12-31 0001308027 VYST:StockOptionPlanMember 2009-04-01 2009-04-30 0001308027 VYST:StockOptionPlanMember 2023-06-30 0001308027 VYST:StockOptionPlanMember VYST:TwoThousandFourteenMember 2023-01-01 2023-06-30 0001308027 VYST:StockOptionPlanMember VYST:TwoThousandNineteenMember 2023-01-01 2023-06-30 0001308027 VYST:StockOptionPlanMember 2023-01-01 2023-06-30 0001308027 VYST:StockOptionsMember 2022-12-31 0001308027 VYST:StockOptionsMember 2022-01-01 2022-12-31 0001308027 VYST:StockOptionsMember 2023-01-01 2023-06-30 0001308027 VYST:StockOptionsMember 2023-06-30 0001308027 VYST:StockWarrantsMember 2022-12-31 0001308027 VYST:StockWarrantsMember 2022-01-01 2022-12-31 0001308027 VYST:StockWarrantsMember 2023-01-01 2023-06-30 0001308027 VYST:StockWarrantsMember 2023-06-30 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember VYST:PerYearMember 2019-07-21 2019-07-22 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember 2019-07-21 2019-07-22 0001308027 VYST:PerStevenRotmanEmploymentAgreementMember 2023-01-01 2023-06-30 0001308027 VYST:StevenRotmanMember 2023-06-30 0001308027 VYST:StevenRotmanMember 2022-12-31 0001308027 VYST:BlueOarConsultingIncMember VYST:PerMonthMember 2023-01-01 2023-06-30 0001308027 VYST:BlueOarConsultingIncMember 2023-01-01 2023-06-30 0001308027 VYST:GregoryRotmanMember 2023-06-30 0001308027 VYST:DesigncentersMember 2023-01-01 2023-06-30 0001308027 2023-01-06 0001308027 us-gaap:SalesMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2023-01-01 2023-06-30 0001308027 us-gaap:SalesMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2023-06-30 0001308027 VYST:PurchaseMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2022-01-01 2022-06-30 0001308027 VYST:PurchaseMember us-gaap:SupplierConcentrationRiskMember VYST:OneMajorVendorMember 2022-06-30 0001308027 us-gaap:TaxYear2020Member 2023-01-01 2023-06-30 0001308027 us-gaap:DomesticCountryMember 2023-06-30 0001308027 VYST:ExpiresBeginningInTwoThousandTwentyFourMember 2023-06-30 0001308027 VYST:CarriedForwardIndefinitelyMember 2023-06-30 0001308027 VYST:GeorgiaCountryMember 2023-06-30 0001308027 VYST:MassachusettsCountryMember 2023-06-30 0001308027 VYST:ExpiresBeginningInTwoThousandTwentyNineMember us-gaap:DomesticCountryMember 2023-06-30 0001308027 VYST:CarriedForwardIndefinitelyMember us-gaap:DomesticCountryMember 2023-06-30 0001308027 us-gaap:StateAndLocalJurisdictionMember VYST:ExpiredBeginningInTwoThousandAndThirtyEightMember 2023-06-30 0001308027 us-gaap:SubsequentEventMember 2023-09-01 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to ________________

 

Commission File Number 000-53754

 

VYSTAR CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Georgia   20-2027731

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

725 Southbridge St

Worcester, MA 01610

(Address of Principal Executive Offices, Zip Code)

 

(508) 791-9114

(Registrant’s telephone number including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
NONE   NONE   NONE

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES ☐ NO

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☐ NO

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer   Smaller reporting company
(Do not check if a smaller reporting company)   Emerging growth company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) YES ☐ NO

 

Class   Outstanding as of October 26, 2023
 Common Stock, $0.0001 par value per share   12,942,592 shares

 

 

 

 
 

 

INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS

 

In addition to historical information, this Form 10-Q contains statements relating to our future results (including certain projections and business trends) that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the “safe harbor” created by those sections. The following discussion of the financial condition and results of operations of the Company should be read in conjunction with the financial statements and the related notes thereto included in this Quarterly Report on Form 10-Q (this “Report”). This Report contains certain forward-looking statements and the Company’s future operating results could differ materially from those discussed herein. Our disclosure and analysis included in this Report concerning our operations, cash flows and financial position, including, in particular, the likelihood of our success in expanding our business and raising debt and capital securities include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “expect”, “anticipate”, “intend”, “plan”, “believe”, “estimate”, “may”, “project”, “will likely result”, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to certain risks, uncertainties, and assumptions, including prevailing market conditions and are more fully described under “Part I, Item 1A - Risk Factors” of our Form 10-K for the year ended December 31, 2022. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. In any event, these and other crucial factors, including those set forth in Item 1A - “Risk Factors” of our Form 10-K for the year ended December 31, 2022 may cause actual results to differ materially from those indicated by our forward-looking statements.

 

Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinions only as of the date of this filing. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements.

 

All references to “we”, “us”, “our” or “Vystar” in this Quarterly Report on Form 10-Q mean Vystar Corporation, and affiliates.

 

2

 

 

VYSTAR CORPORATION

 

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2023

 

INDEX

 

Part I. Financial Information  
     
Item 1. Financial Statements: 4
     
  Condensed Consolidated Balance Sheets at June 30, 2023 (unaudited) and December 31, 2022 4
     
  Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 (unaudited) and 2022 (unaudited) 5
     
  Condensed Consolidated Statements of Stockholders’ Deficit for the Three and Six Months Ended June 30, 2023 (unaudited) and 2022 (unaudited) 6-7
     
  Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 (unaudited) and 2022 (unaudited) 8
     
  Notes to Condensed Consolidated Financial Statements (unaudited) 9
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 27
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 32
     
Item 4. Controls and Procedures 33
     
Part II. Other Information  
   
Item 1. Legal Proceedings 34
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34
     
Item 3. Defaults Upon Senior Securities 34
     
Item 4. Mine Safety Disclosures 34
     
Item 5. Other Information 34
     
Item 6. Exhibits 34
     
SIGNATURES 35

 

3

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   June 30,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS          
Current assets:          
Cash  $49,517   $12,274 
Accounts receivable   13,616    12,145 
Inventories   69,860    91,724 
Prepaid expenses and other   644,884    633,769 
Assets of discontinued operations   751,404    3,026,971 
           
Total current assets   1,529,281    3,776,883 
           
Property and equipment, net   119,106    140,886 
           
Other assets:          
Intangible assets, net   138,513    154,371 
Inventories, long-term   -    63,009 
Assets of discontinued operations   6,762,448    7,503,970 
           
Total other assets   6,900,961    7,721,350 
           
Total assets  $8,549,348   $11,639,119 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
Current liabilities:          
Accounts payable  $1,514,098   $1,361,483 
Accrued expenses   326,588    684,147 
Stock subscription payable   1,901,322    1,655,208 
Shareholder, convertible and contingently convertible notes payable and accrued interest - current maturities     344,293       336,263  
Related party debt - current maturities   173,177    169,552 
Unearned revenue   44,379    44,479 
Related party advances   299,884    266,541 
Liabilities of discontinued operations   1,394,980    2,328,589 
           
Total current liabilities   5,998,721    6,846,262 
           
Long-term liabilities:          
Liabilities of discontinued operations   5,069,980    5,513,667 
           
Total liabilities   11,068,701    12,359,929 
           
Stockholders’ deficit:          
Convertible preferred stock series class A, $0.0001 par value 15,000,000 shares authorized; 8,698 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively (liquidation preference of $175,000 and $170,000 at June 30, 2023 and December 31, 2022, respectively)   1    1 
Convertible preferred stock series B, $0.0001 par value 2,500,000 shares authorized; 370,969 shares issued and outstanding at June 30, 2023 and December 31, 2022 (liquidation preference of $2,839,000 and $2,710,000 at June 30, 2023 and December 31, 2022, respectively)   37    37 
Convertible preferred stock series C, $0.0001 par value 2,500,000 shares authorized; 1,917,973 shares issued and outstanding at June 30, 2023 and December 31, 2022 (liquidation preference of $5,481,000 and $5,233,000 at June 30, 2023 and December 31, 2022, respectively)   192    192 
Common stock, $0.0001 par value, 500,000,000 shares authorized; 12,942,892 shares issued at June 30, 2023 and December 31, 2022, and 12,942,592 shares outstanding at June 30, 2023 and December 31, 2022, respectively   1,294    1,294 
Additional paid-in capital   53,361,925    53,361,925 
Accumulated deficit   (56,563,715)   (55,368,868)
Common stock in treasury, at cost; 300 shares   (30)   (30)
           
Total Vystar stockholders’ deficit   (3,200,296)   (2,005,449)
           
Noncontrolling interest   680,943    1,284,639 
           
Total stockholders’ deficit   (2,519,353)   (720,810)
           
Total liabilities and stockholders’ deficit  $8,549,348   $11,639,119 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Revenue  $36,126   $45,323   $446,033   $168,843 
                     
Cost of revenue   5,913    25,942    82,611    64,167 
                     
Gross profit   30,213    19,381    363,422    104,676 
                     
Operating expenses:                    
Salaries, wages and benefits   74,282    59,495    129,211    118,833 
Share-based compensation   107,204    338,857    246,114    476,805 
Professional fees   6,269    22,146    61,711    154,959 
Advertising   3,561    7,981    10,226    14,215 
Rent   20,001    -    40,002    8,393 
Service charges   3,568    2,437    4,372    4,206 
Depreciation and amortization   18,819    35,119    37,638    70,238 
Other operating   85,446    140,213    173,802    342,499 
                     
Total operating expenses   319,150    606,248    703,076    1,190,148 
                     
Loss from operations   (288,937)   (586,867)   (339,654)   (1,085,472)
                     
Other income (expense):                    
Interest expense   (11,181)   (111,489)   (21,518)   (196,204)
Change in fair value of derivative liabilities   -    1,463,000    -    1,520,000 
Gain (loss) on settlement of debt, net   -    230,820    -    230,820 
                     
Total other income (expense), net   (11,181)   1,582,331    (21,518)   1,554,616 
                     
Net income (loss) from continuing operations   (300,118)   995,464    (361,172)   469,144 
                     
Discontinued operations:                    
Loss from operations   (221,349)   (566,869)   (1,437,371)   (994,515)
                     
Net income (loss)   (521,467)   428,595    (1,798,543)   (525,371)
                     
Net loss attributable to noncontrolling interest   92,967    238,084    603,696    417,696 
                     
Net income (loss) attributable to Vystar  $(428,500)  $666,679   $(1,194,847)  $(107,675)
                     
Basic and diluted loss per share:                    
Net income (loss) from continuing operations  $(0.02)  $0.08   $(0.03)  $0.04 
Net loss from discontinued operations  $(0.02)  $(0.04)  $(0.11)  $(0.08)
Net loss attributable to noncontrolling interest  $(0.01)  $(0.02)  $(0.05)  $(0.03)
Net income (loss) attributable to common shareholders  $(0.03)  $0.05   $(0.09)  $(0.01)
                     
Basic and diluted weighted average number of common shares outstanding  
 
 
 
 
12,942,592
 
 
 
 
 
 
 
12,942,592
 
 
 
 
 
 
 
12,942,592
 
 
 
 
 
 
 
12,942,618
 
 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE SIX MONTHS ENDED JUNE 30, 2023

(Unaudited)

 

   Shares A   Stock A   Shares B   Stock B   Shares C   Stock C   Shares   Stock   Capital   Deficit   Shares   Stock   Deficit   Interest   Deficit 
   Attributable to Vystar         
   Number       Number       Number       Number               Number       Total         
   of       of       of       of       Additional       of       Vystar       Total 
   Preferred   Preferred   Preferred   Preferred   Preferred   Preferred   Common   Common   Paid-in   Accumulated   Treasury   Treasury   Stockholders’   Noncontrolling   Stockholders’ 
   Shares A   Stock A   Shares B   Stock B   Shares C   Stock C   Shares   Stock   Capital   Deficit   Shares   Stock   Deficit   Interest   Deficit 
                                                             
Ending balance December 31, 2022   8,698   $1    370,969   $37    1,917,973   $192    12,942,592   $1,294   $53,361,925   $(55,368,868)   (300)  $(30)  $(2,005,449)  $1,284,639   $(720,810)
                                                                            
Net loss   -    -    -    -    -    -    -    -    -    (766,347)   -    -    (766,347)   (510,729)   (1,277,076)
                                                                            
Ending balance March 31, 2023   8,698    1    370,969           37    1,917,973        192    12,942,592    1,294    53,361,925    (56,135,215)   (300)   (30)   (2,771,796)   773,910    (1,997,886)
                                                                            
Net loss   -    -    -    -    -    -    -    -    -    (428,500)   -    -    (428,500)   (92,967)   (521,467)
                                                                            
Ending balance June 30, 2023   8,698   $1    370,969   $37    1,917,973   $192    12,942,592   $1,294   $53,361,925   $(56,563,715)   (300)  $(30)  $(3,200,296)  $680,943   $(2,519,353)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE SIX MONTHS ENDED JUNE 30, 2022

(Unaudited)

 

   Shares A   Stock A   Shares B   Stock B   Shares C   Stock C   Shares   Stock   Capital   Deficit   Shares   Stock   Deficit   Interest   Deficit 
   Attributable to Vystar         
   Number       Number       Number       Number               Number       Total         
   of       of       of       of       Additional       of       Vystar       Total 
   Preferred   Preferred   Preferred   Preferred   Preferred   Preferred   Common   Common   Paid-in   Accumulated   Treasury   Treasury   Stockholders’   Noncontrolling   Stockholders’ 
   Shares A   Stock A   Shares B   Stock B   Shares C   Stock C   Shares   Stock   Capital   Deficit   Shares   Stock   Deficit   Interest   Deficit 
                                                             
Ending balance December 31, 2021   8,698   $         1         -   $-    -   $-    12,942,792   $1,294   $43,851,510   $(51,410,516)   (300)  $(30)  $(7,557,741)  $1,657,442   $(5,900,299)
                                                                            
Share-based compensation - options                                           3,691                   3,691         3,691 
                                                                            
Retirement of common stock                                 (200)                                      - 
                                                                            
Net loss   -    -    -    -    -    -    -    -    -    (774,354)   -    -    (774,354)   (179,612)   (953,966)
                                                                            
Ending balance March 31, 2022   8,698    1    -    -    -    -    12,942,592    1,294    43,855,201    (52,184,870)   (300)   (30)   (8,328,404)   1,477,830    (6,850,574)
                                                                            
Share-based compensation - options                                           3,691                   3,691         3,691 
                                                                            
Net income   -    -    -    -    -    -    -    -    -    666,679    -    -    666,679    (238,084)   428,595 
                                                                            
Ending balance June 30, 2022   8,698   $1    -   $-    -   $-    12,942,592   $1,294   $43,858,892   $(51,518,191)   (300)  $(30)  $(7,658,034)  $1,239,746   $(6,418,288)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

7

 

 

VYSTAR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   2023   2022 
   Six Months Ended 
   June 30, 
   2023   2022 
Cash flows from operating activities:          
Net loss  $(1,798,543)  $(525,371)
Adjustments to reconcile net loss to net cash used in operating activities:          
Share-based compensation   246,114    476,805 
Depreciation   31,604    128,536 
Bad debts (recovery)   1,566    (4,039)
Amortization of intangible assets   15,858    172,624 
Noncash lease expense   73,408    153,016 
Amortization of debt discount   -    27,083 
Change in fair value of derivative liabilities   -    (1,520,000)
Gain on settlement of debt, net   (39,770)   (230,820)
Gain on sale of property and equipment   (213,776)   - 
(Increase) decrease in assets:          
Accounts receivable   1,500    1,833 
Inventories   84,873    25,504 
Prepaid expenses and other   (11,115)   61,645 
Assets of discontinued operations   2,278,817    843,994 
Increase (decrease) in liabilities:          
Accounts payable   152,615    294,907 
Accrued expenses and interest payable   (345,903)   77,804 
Unearned revenue   (100)   (33,759)
Liabilities of discontinued operations   (642,340)   (457,171)
           
Net cash used in operating activities   (165,192)   (507,409)
           
Cash flows from investing activities:          
Cash flows provided by discontinued operations   579,483    - 
           
Cash flows from financing activities:          
Proceeds from related party advances   33,343    69,820 
Cash flows provided by (used in) discontinued operations   (402,604)   356,437 
           
Net cash provided by (used in) financing activities   (369,261)   426,257 
           
Net increase (decrease) in cash   45,030    (81,152)
           
Cash - beginning of period   135,599    151,175 
Less: cash of discontinued operations   (131,112)   (53,020)
           
Cash of continuing operations - end of period  $49,517   $17,003 
           
Cash paid during the period for:          
Interest  $9,863   $191,183 
           
Non-cash transactions:          
Rotmans vendor payables paid directly by related party  $-   $100,000 
Stock subscription payable recorded for consulting and exercise of outstanding options and warrants   -    58,500 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

8

 

 

VYSTAR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

Nature of Business

 

Vystar Corporation (“Vystar”, the “Company”, “we,” “us,” or “our”) is based in Worcester, Massachusetts. The Company uses patented technology to produces a line of innovative air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. Vystar is also the creator and exclusive owner to produce Vytex® Natural Rubber Latex (“NRL”) currently being used primarily in various bedding products. In addition, Vystar has a majority ownership in Murida Furniture Co., Inc. dba Rotmans Furniture (“Rotmans”), formerly one of the largest independent furniture retailers in the U.S.

 

All activities of Rotmans have been included in discontinued operations. Additional disclosure can be found in Note 15.

 

NOTE 2 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for the fair presentation of the condensed consolidated financial statements have been included. Such adjustments are of a normal, recurring nature. The condensed consolidated financial statements, and the accompanying notes, are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and do not contain certain information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Therefore, the interim condensed consolidated financial statements should be read in conjunction with that Annual Report on Form 10-K.

 

The Company has evaluated subsequent events through the date of the filing of its Form 10-Q with the Securities and Exchange Commission. Other than those events disclosed in Note 16, the Company is not aware of any other significant events that occurred subsequent to the balance sheet date but prior to the filing of this report that would have a material impact on the Company’s financial statements.

 

Basis of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned or controlled operating subsidiaries. All significant intercompany accounts and transactions have been eliminated.

 

Discontinued Operations

 

In accordance with ASC No. 205-20, Discontinued Operations, for all periods presented, the results of operations and related balance sheet items associated with Rotmans are reported in discontinued operations in the accompanying consolidated financial statements. See Note 15 for further details.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets, generally 5 to 10 years, using straight-line and accelerated methods.

 

Expenditures for major renewals and betterments are capitalized, while routine repairs and maintenance are expensed as incurred. When property items are retired or otherwise disposed of, the asset and related reserve accounts are relieved of the cost and accumulated depreciation, respectively, and the resultant gain or loss is reflected in earnings. As of June 30, 2023, the net balance of property and equipment is $119,106 with accumulated depreciation of $223,297. As of December 31, 2022, the net balance of property and equipment is $140,886 with accumulated depreciation of $201,517.

 

9

 

 

Unearned Revenue

 

Unearned revenue consists of customer advance payments, deposits on sales of undelivered merchandise and deferred warranty revenue on self-insured stain protection warranty coverage.

 

Changes to unearned revenue during the six months ended June 30, 2023 and 2022 are summarized as follows:

 

   2023   2022 
         
Balance, beginning of the period  $44,479   $79,368 
           
Customer deposits received   -    300 
           
Revenue earned   (100)   (34,058)
           
Balance, end of the period  $44,379   $45,610 

 

Income (Loss) Per Share

 

The Company presents basic and diluted income (loss) per share. For the three and six months ended June 30, 2023 and 2022, common stock equivalents, including stock options and warrants, were anti-dilutive; therefore, the amounts reported for basic and dilutive income (loss) per share were the same. Excluded from the computation of diluted income (loss) per share were options to purchase 25,982 and 265,250 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would be anti-dilutive. Warrants to purchase 43,267 and 38,859 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, were also excluded from the computation of diluted income (loss) per share as their effect would be anti-dilutive. In addition, preferred stock convertible to 25,088,511 and 32,434 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, were excluded from the computation of diluted income (loss) per share as their effect would be anti-dilutive. Both shareholder and Rotman Family contingently convertible notes for the six months ended June 30, 2023 and 2022 were also excluded from the computation of diluted income (loss) per share as no contingencies were met.

 

Revenue

 

Our principal activities from which we generate our revenue are product sales. Revenue is measured based on considerations specified in a contract with a customer. A contract exists when it becomes a legally enforceable agreement with a customer. The contract is based on either the acceptance of standard terms and conditions at the retail store and on the websites for e-commerce customers, or the execution of terms and conditions contracts with retailers and wholesalers. These contracts define each party’s rights, payment terms and other contractual terms and conditions of the sale.

 

Consideration is typically paid prior to shipment via credit card or check when our products are sold direct to consumers, which is typically within 1 to 2 days or approximately 30 days from the time control is transferred when sold to wholesalers, distributors and retailers. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience and, in some circumstances, published credit and financial information pertaining to the customer.

 

10

 

 

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for us is transfer of finished goods to our customers. Performance obligations promised in a contract are identified based on the goods that will be transferred to the customer that are both capable of being distinct and are distinct in the context of the contract, whereby the transfer of the goods is separately identifiable from other promises in the contract. We have concluded the sale of finished goods and related shipping and handling are accounted for as the single performance obligation.

 

The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods to the customer. We issue refunds to retail, e-commerce and print media customers, upon request, within 30 days of delivery. We estimate the amount of potential refunds at each reporting period using a portfolio approach of historical data, adjusted for changes in expected customer experience, including seasonality and changes in economic factors. For retailers, distributors and wholesalers, we do not offer a right of return or refund and revenue is recognized at the time products are shipped to customers. Our RxAir units carry a one year warranty. In all cases, judgment is required in estimating these reserves. Actual claims for returns could be materially different from the estimates. As of June 30, 2023 and December 31, 2022, reserves for estimated sales returns totaled $49,000 and $415,000, respectively, and are included in the accompanying condensed consolidated balance sheets as accrued expenses.

 

We recognize revenue when we satisfy a performance obligation in a contract by transferring control over a product to a customer when product is shipped based on fulfillment by the Company. The Company considers fulfillment when it passes all liability at the point of shipping through third party carriers. Delivery fees are charged to customers and are included in revenue in the accompanying condensed consolidated statements of operations and the costs associated with these deliveries are included in revenues as third party carrier are engaged. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of revenue in the accompanying condensed consolidated statements of operations.

 

Advertising Costs

 

Advertising costs, which include television, radio, newspaper, digital and other media advertising, are expensed upon first showing. Advertising costs were approximately $10,000 and $14,000 for the six months ended June 30, 2023 and 2022, respectively.

 

NOTE 3 - LIQUIDITY AND GOING CONCERN

 

The Company’s financial statements are prepared using the accrual method of accounting in accordance with U.S. GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. However, the Company has incurred significant losses and experienced negative cash flow since inception. At June 30, 2023, the Company had cash of $49,517 and a deficit in working capital of approximately $4.4 million. Further, at June 30, 2023, the accumulated deficit amounted to approximately $56.6 million. We use working capital to finance our ongoing operations, and since those operations do not currently cover all our operating costs, managing working capital is essential to our Company’s future success. Because of this history of losses and financial condition, there is substantial doubt about the Company’s ability to continue as a going concern.

 

A successful transition to attaining profitable operations is dependent upon obtaining sufficient financing to fund the Company’s planned expenses and achieving a level of revenue adequate to support the Company’s cost structure. Management plans to finance future operations using cash on hand, increased revenue from RxAir air purification units, Vytex license fees and stock issuances to new and existing shareholders.

 

11

 

 

There can be no assurances the Company will be able to achieve projected levels of revenue in 2023 and beyond. If the Company is not able to achieve projected revenue and obtain alternate additional financing of equity or debt, the Company would need to significantly curtail or reorient operations during 2023, which could have a material adverse effect on the ability to achieve the business objectives, and as a result, may require the Company to file bankruptcy or cease operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions.

 

The Company’s future expenditures will depend on numerous factors, including: the rate at which the Company can introduce RxAir air purification units and license Vytex NRL raw materials to manufacturers, and subsequently retailers; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance of the Company’s products, services and competing technological developments; the Company’s ability to successfully acquire new customers and maintain a strong brand; and broader economic factors such as interest rates and changes in customer spending patterns. As the Company expands its activities and operations, cash requirements are expected to increase at a rate consistent with revenue growth after the Company has achieved sustained revenue generation.

 

NOTE 4 - PROPERTY AND EQUIPMENT

 

Property and equipment, net consists of the following:

 

   June 30,   December 31, 
   2023   2022 
         
Tooling and testing equipment  $338,572   $338,572 
Furniture, fixtures and equipment   3,831    3,831 
           
Property and equipment, gross   342,403    342,403 
Accumulated depreciation   (223,297)   (201,517)
           
Property and equipment, net  $119,106   $140,886 

 

Depreciation expense for the six months ended June 30, 2023 and 2022 was $21,780.

 

12

 

 

NOTE 5 - INTANGIBLE ASSETS

 

Intangible assets consist of the following:

 

           Amortization 
   June 30,   December 31,   Period 
   2023   2022   (in Years) 
Amortized intangible assets:               
Patents  $361,284   $361,284    6 - 20 
Proprietary technology   13,000    13,000    10 
Tradename and brand   13,000    13,000    5 - 10 
                
Total   387,284    387,284      
Accumulated amortization   (257,843)   (241,985)     
                
Intangible assets, net   129,441    145,299      
Indefinite-lived intangible assets:               
Trademarks   9,072    9,072      
                
Total intangible assets  $138,513   $154,371      

 

Amortization expense for the six months ended June 30, 2023 and 2022 was $15,858 and $48,458, respectively.

 

Estimated future amortization expense for finite-lived intangible assets is as follows:

 

   Amount 
     
Remaining in 2023  $15,858 
2024   31,716 
2025   24,652 
2026   16,032 
2027   16,032 
Thereafter   25,151 
      
Total  $129,441 

 

NOTE 6 - LEASES (DISCONTINUED OPERATIONS)

 

Rotmans leases equipment, a showroom, offices and warehouse facilities. These leases expire at various dates through 2031 and have monthly base rents which range from $800 to $81,000. One of the leases may be terminated early by the lessor at the end of 2028 with a six-month notice.

 

13

 

 

The table below presents the lease costs for the three and six months ended June 30, 2023 and 2022:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Operating lease cost  $141,064   $288,134   $306,250   $575,804 
                     
Finance lease cost:                    
                     
Amortization of right-of-use assets   -    39,706    -    84,174 
Interest on lease liabilities   -    6,785    -    14,097 
                     
Total lease cost  $141,064   $334,625   $306,250   $674,075 

 

During the six months ended June 30, 2023 and 2022, the Company recognized sublease income of approximately $14,000 and $68,000, respectively, which in included in discontinued operations in the accompanying condensed consolidated statements of operations.

 

Our leases generally do not provide an implicit rate, and therefore we use our incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease. We used incremental borrowing rates as of the implementation date for operating leases that commenced prior to that date.

 

The following table presents other information related to leases:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Cash paid for amounts included in the measurement of lease liabilities:                    
                     
Operating cash flows used for operating leases  $217,500   $262,004   $463,424   $525,620 
Financing cash flows used for financing leases   -    45,499    -    95,160 
                     
Assets obtained in exchange for operating lease liabilities   -    -    -    - 
                     
Assets obtained in exchange for finance lease liabilities   -    -    -    - 
                     
Weighted average remaining lease term:                    
Operating leases   7.6 years    8.6 years     7.6 years    8.6 years 
Finance leases   2.9 years    3.9 years    2.9 years    3.9 years 
                     
Weighted average discount rate:                    
Operating leases   5.60%   5.60%   5.60%   5.60%
Finance leases   5.16%   5.16%   5.16%   5.16%

 

14

 

 

The future minimum lease payments required under operating and financing lease obligations as of June 30, 2023 having initial or remaining non-cancelable lease terms in excess of one year are summarized as follows:

 

   Operating Leases   Finance Leases   Total 
             
Remainder of 2023  $585,927   $139,080   $725,007 
2024   955,272    139,080    1,094,352 
2025   870,000    139,080    1,009,080 
2026   870,000    68,395    938,395 
2027   870,000    -    870,000 
Thereafter   2,682,500    -    2,682,500 
                
Total undiscounted lease liabilities   6,833,699    485,635    7,319,334 
Less: imputed interest   (1,215,246)   (42,108)   (1,257,354)
                
Net lease liabilities  $5,618,453   $443,527   $6,061,980 

 

As of June 30, 2023, Vystar and Rotmans do not have additional operating and finance leases that have not yet commenced.

 

NOTE 7 - NOTES PAYABLE AND LOAN FACILITY

 

Discontinued Operations

 

Advances/Receivable

 

On May 29, 2020, Rotmans entered into a sale promotion consulting agreement with a national furniture sales event company. Under the agreement, Rotmans appointed the third-party as its exclusive agent to assist with a high-impact sale. Before the sale, the agent advanced the Company funds of approximately $2,300,000 to pay off a bank line of credit and certain other vendors. The agent was reimbursed for the advance from the proceeds of the sale. The initial sales agreement with the agent ended in May 2021. The agreement has been amended numerous times and ended in December 2022. At the conclusion of the agreement, the remaining inventories were transferred to the agent. As of June 30, 2023 and December 31, 2022, a receivable is due from the agent for the inventories in the amount of $187,342 and $1,853,972, respectively, and is included in assets of discontinued operations.

 

Continuing Operations

 

Shareholder, Convertible and Contingently Convertible Notes Payable

 

The following table summarizes shareholder, convertible and contingently convertible notes payable:

 

   June 30,
2023
   December 31,
2022
 
         
Shareholder, convertible and contingently convertible notes  $309,500   $309,500 
Accrued interest   34,793    26,763 
           
Total shareholder notes and accrued interest   344,293    336,263 
           
Less: current maturities   (344,293)   (336,263)
           
Total long-term debt  $-   $- 

 

15

 

 

Shareholder Convertible Notes Payable

 

During the year ended December 31, 2021, the Company issued certain contingently convertible promissory notes in varying amounts to existing shareholders which totaled $290,000. The notes are unsecured and bear interest at an annual rate of five percent (5%) from date of issuance. The face amount of the notes represents the amount due at maturity along with the accrued interest. In the event that the spin-off of RxAir does not occur within 2023, the Company will convert these notes into common stock at a conversion price of $1.60. If the spin-off does occur, these notes will convert into RxAir common stock with two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18. All of these notes are outstanding as of June 30, 2023 and December 31, 2022. At the issuance date of these notes, it was determined they contain a beneficial conversion feature amounting to approximately $90,000. As these notes are contingently convertible, the beneficial conversion feature will not be recorded on the consolidated financial statements until the actual conversion occurs.

 

One note remains from the Company’s issuance of shareholder contingently convertible notes payable in 2018 and is (i) unsecured, (ii) bore interest at an annual rate of five percent (5%) from date of issuance, and (iii) is convertible at the Company’s option post April 19, 2018. The note matured one year from issuance and was extended one (1) additional year by the Company. If converted, the note plus accrued interest are convertible into shares of the Company’s common stock at the prior twenty (20) day average closing price with a 50% discount. The outstanding balance as of June 30, 2023 and December 31, 2022 is $19,500. The note matured in January 2020 and continues to accrue interest until settlement. The note is in default and bears interest at an annual rate of eight percent (8%) in arrears. The value of the embedded conversion features on the one remaining note was de minimis at June 30, 2023 and December 31, 2022.

 

Related Party Debt

 

The following table summarizes related party debt:

 

   June 30,   December 31, 
   2023   2022 
         
Rotman Family convertible notes  $5,000   $5,000 
Rotman Family nonconvertible notes   140,000    140,000 
Accrued interest   28,177    24,552 
           
Due to related party   173,177    169,552 
Less: current maturities   (173,177)   (169,552)
           
Due to related party, noncurrent  $-   $- 

 

Rotman Family Convertible Note

 

On August 17, 2021, the Company issued a contingently convertible promissory note totaling $5,000 to Jamie Rotman. The note is unsecured and bears interest at an annual rate of five percent (5%) from date of issuance. The face amount of the note represents the amount due at maturity along with the accrued interest. In the event that the spin-off of RxAir does not occur within one year, the Company will convert the note into common stock at a conversion price of $1.60. If the spin-off does occur, the note will convert into RxAir common stock with two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18. At the issuance date of this note, it was determined to contain a beneficial conversion feature amounting to approximately $2,000. As this note is contingently convertible, the beneficial conversion feature will not be recorded on the consolidated financial statements until the actual conversion occurs. The balance of the note payable including accrued interest to Jamie Rotman is approximately $5,000 at June 30, 2023 and December 31, 2022.

 

16

 

 

The following table summarizes the Rotman Family Convertible Note:

 

   Issue Date  Principal Amount   2023   2022 
          Carrying Amount 
          June 30,   December 31, 
   Issue Date  Principal Amount   2023   2022 
Jamie Rotman 5.00% note due August 2023  08/17/21  $5,000   $5,469   $5,344 

 

Rotman Family Nonconvertible Note

 

In connection with the acquisition of 58% of Rotmans, Bernard Rotman was issued a related party note payable in the amount of $140,000. The note bears interest at an annual rate of five percent (5%) and matures four years from issuance. Monthly payments of $2,917 to Bernard Rotman were scheduled to begin six months from issuance until maturity in December 2023. The balance of Bernard Rotman’s note including accrued interest is approximately $168,000 and $164,000 at June 30, 2023 and December 31, 2022, respectively, as no payments have been made to date.

 

The following table summarizes the Rotman Family Nonconvertible Note:

 SCHEDULE OF NOTES PAYABLE

   Issue Date  Principal Amount   2023   2022 
          Carrying Amount 
          June 30,   December 31, 
   Issue Date  Principal Amount   2023   2022 
Bernard Rotman 5.00% note due July 2023  07/18/19  $140,000   $167,708   $164,208 

 

Discontinued Operations Note

 

In April 2022, Blue Oar Consulting, Inc. (“Blue Oar”), an entity wholly owned by Gregory Rotman, advanced Rotmans $500,000 and paid bills totaling $100,000 on Rotmans behalf. Rotmans formalized the advances and issued a promissory note to Blue Oar. The note bore interest at an annual rate of six percent (6%) and required weekly payments of $12,500 until the note and interest is paid in full. The Company also granted Blue Oar a security interest in its inventory. The final principal payment on the note balance was made in April 2023. As of June 30, 2023, unpaid accrued interest on the note totaled $22,518. As of December 31, 2022, the balance of the note payable including accrued interest was approximately $407,000 and is included in liabilities from discontinued operations.

 

NOTE 8 - STOCKHOLDERS’ DEFICIT

 

Cumulative Convertible Preferred Stock

 

Series A Preferred Stock

 

On May 2, 2013, the Company began a private placement offering to sell up to 200,000 shares of the Company’s 10% Series A Cumulative Convertible Preferred Stock. Under the terms of the offering, the Company offered to sell up to 200,000 shares of preferred stock at $10 per share for a value of $2,000,000. The preferred stock was convertible at a conversion price of $7.50 per common share at the option of the holder after a nine-month holding period. The conversion price was lowered to $5.00 per common share for those holders who invested an additional $25,000 or more in Vystar’s common stock in the aforementioned September 2014 Private Placement. The preferred shares have full voting rights as if converted and have a fully participating liquidation preference. In the event of a liquidation, dissolution or winding up of the Company, the holders of Series A Preferred Stock shall be entitled to receive an amount equal to the dividends accumulated and unpaid thereon to the date of final distribution to such holders, whether or not declared, without interest, plus a sum equal to $10 per share. As of June 30, 2023 and December 31, 2022, the liquidation preference totals approximately $175,000 and $170,000, respectively.

 

17

 

 

As of June 30, 2023, the 8,698 shares of outstanding preferred stock had undeclared dividends of approximately $88,000 and could be converted into 34,135 shares of common stock, at the option of the holder.

 

As of December 31, 2022, the 8,698 shares of outstanding preferred stock had undeclared dividends of approximately $83,000 and could be converted into 33,292 shares of common stock, at the option of the holder.

 

Series B Preferred Stock

 

On April 11, 2022, the Company amended its Articles of Incorporation to add the terms of a 10% Series B Cumulative Convertible Preferred Stock. Under the amendment, the number of shares authorized are 2,500,000. The preferred stock accumulates a 10% per annum dividend and is convertible into 1,000 shares of common stock at the option of the holder after a six-month holding period. The holders of Series B preferred stock have full voting rights as if converted and have a fully participating liquidation preference. In the event of a liquidation, dissolution or winding up of the Company, the holders of Series B Preferred Stock shall be entitled to receive an amount equal to the dividends accumulated and unpaid thereon to the date of final distribution to such holders, whether or not declared, without interest, plus a sum equal to $7 per share. As of June 30, 2023 and December 31, 2022, the liquidation preference totals approximately $2,839,000 and $2,710,000, respectively.

 

As of June 30, 2023, the 370,969 shares of outstanding preferred stock had undeclared dividends of approximately $242,000 and could be converted into 4,055,250 shares of common stock, at the option of the holder.

 

As of December 31, 2022, the 370,969 shares of outstanding preferred stock had undeclared dividends of approximately $108,000 and could be converted into 3,864,261 shares of common stock, at the option of the holder.

 

Series C Preferred Stock

 

On July 8, 2022, the Company amended its Articles of Incorporation to add the terms of a 10% Series C Cumulative Convertible Preferred Stock. Under the amendment, the number of shares authorized are 2,500,000. The preferred stock accumulates a 10% per annum dividend and is convertible into 1,000 shares of common stock at the option of the holder after a six-month holding period. The holders of Series C preferred stock have full voting rights as if converted and have a fully participating liquidation preference. In the event of a liquidation, dissolution or winding up of the Company, the holders of Series C Preferred Stock shall be entitled to receive an amount equal to the dividends accumulated and unpaid thereon to the date of final distribution to such holders, whether or not declared, without interest, plus a sum equal to $2.61 per share. As of June 30, 2023 and December 31, 2022, the liquidation preference totals approximately $5,481,000 and $5,233,000, respectively.

 

As of June 30, 2023, the 1,917,973 shares of outstanding preferred stock had undeclared dividends of approximately $475,000 and could be converted into 20,999,125 shares of common stock, at the option of the holder.

 

As of December 31, 2022, the 1,917,973 shares of outstanding preferred stock had undeclared dividends of approximately $325,000 and could be converted into 20,425,550 shares of common stock, at the option of the holder.

 

Common Stock and Warrants

 

Included in stock subscription payable at June 30, 2023 and December 31, 2022, is $270,000 received under common stock subscription agreements for 180,000 shares during the year ended December 31, 2020.

 

18

 

 

Stock Subscription Payable

 

At June 30, 2023 and December 31, 2022, the Company recorded $1,901,322 and $1,655,208, respectively, of stock subscription payable related to common stock to be issued. The following summarizes the activity of stock subscription payable during the period ended June 30, 2023 and December 31, 2022:

 

   Amount   Shares 
         
Balance, January 1, 2022  $1,247,549    605,058 
Additions   659,647    1,552,386 
Issuances   (251,988)   (25,568)
           
Balance, December 31, 2022   1,655,208    2,131,876 
Additions   246,114    3,455,456 
           
Balance, June 30, 2023  $1,901,322    5,587,332 

 

NOTE 9 - REVENUES

 


The following table presents our revenues disaggregated by each major product category and service for the three and six months ended June 30, 2023 and 2022:

 

   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
       % of       % of       % of       % of 
   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales 
Air Purification Units  $20,169    55.8   $38,941    85.9   $423,865    95.0   $142,231    84.2 
Mattresses and Toppers   13,895    38.5    5,126    11.3    19,906    4.5    17,640    10.5 
Other   2,062    5.7    1,256    2.8    2,262    0.5    8,972    5.3 
Net sales  $36,126    100.0   $45,323    100.0   $446,033    100.0   $168,843    100.0 

 

NOTE 10 - SHARE-BASED COMPENSATION

 

Generally accepted accounting principles require share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income statement based on their fair values at the date of grant, net of estimated forfeitures.

 

In total, the Company recorded $246,114 and $476,805 of stock-based compensation for the six months ended June 30, 2023 and 2022, respectively, including shares to be issued related to consultants and board member stock options and common stock and warrants issued to non-employees. Included in stock subscription payable is accrued stock-based compensation of $1,631,322 and $1,385,208 at June 30, 2023 and December 31, 2022, respectively.

 

The Company used the Black-Scholes option pricing model to estimate the grant-date fair value of option and warrant awards:

 

  Expected Dividend Yield - because the Company does not currently pay dividends, the expected dividend yield is zero;
  Expected Volatility in Stock Price - volatility based on the Company’s trading activity was used to determine expected volatility;
  Risk-free Interest Rate - reflects the average rate on a United States Treasury Bond with a maturity equal to the expected term of the option; and
  Expected Life of Award - because we have minimal experience with the exercise of options or warrants for use in determining the expected life of each award, we used the option or warrant’s contractual term as the expected life.

 

 

In total for the six months ended June 30, 2022, the Company recorded $7,682 of share-based compensation expense related to employee and Board Members’ stock options. The Company did not recognize any such share-based compensation for the six months ended June 30, 2023. There is no unrecognized compensation expense as of June 30, 2023 for non-vested share-based awards to be recognized over a period of less than one year.

 

19

 

 

Options

 

During 2004, the Board of Directors of the Company adopted a stock option plan (the “Plan”) and authorized up to 40,000 shares to be issued under the Plan. In April 2009, the Company’s Board of Directors authorized an increase in the number of shares to be issued under the Plan to 100,000 shares and to include the independent Board Members in the Plan in lieu of continuing the previous practice of granting warrants each quarter to independent Board Members for services. At June 30, 2023, there are 22,518 shares of common stock available for issuance under the Plan. In 2014, the Board of Directors adopted an additional stock option plan which provides for an additional 50,000 shares which are all available as of June 30, 2023. In 2019, the Board of Directors adopted an additional stock option plan with provides for 500,000 shares which are all available as of June 30, 2023. The Plan is intended to permit stock options granted to employees to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the Plan that are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options. Stock options are granted at an exercise price equal to the fair market value of the Company’s common stock on the date of grant, typically vest over periods up to 4 years and are typically exercisable up to 10 years.

 

There were no options granted during the six months ended June 30, 2023 and 2022, respectively. Forfeitures are recognized as they occur.

 

The following table summarizes all stock option activity of the Company for the six months ended June 30, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number   Exercise   Contractual 
   of Shares   Price   Life (Years) 
             
Outstanding, December 31, 2022   265,267   $19.54    0.51 
                
Granted   -    -    - 
                
Exercised   -    -    - 
                
Forfeited   (222,000)  $21.95    - 
                
Outstanding, June 30, 2023   43,267   $7.16    0.96 
                
Exercisable, June 30, 2023   43,267   $7.16    0.96 

 

As of June 30, 2023 and 2022, the aggregate intrinsic value of the Company’s outstanding options was minimal. The aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

 

Warrants

 

Warrants are issued to third parties as payment for services, debt financing compensation and conversion and in conjunction with the issuance of common stock. The fair value of each common stock warrant issued for services is estimated on the date of grant using the Black-Scholes option pricing model.

 

20

 

 

The following table represents the Company’s warrant activity for the six months ended June 30, 2023:

 

               Weighted 
               Average 
       Weighted   Weighted   Remaining 
   Number   Average   Average   Contractual 
   of Shares   Fair Value   Exercise Price   Life (Years) 
                 
                 
Outstanding, December 31, 2022   37,266    -   $7.57    1.31 
                     
Granted   -        -    -    - 
                     
Exercised   -    -    -    - 
                     
Forfeited   -    -    -    - 
                     
Expired   (11,284)   -   $32.22    - 
                     
Outstanding, June 30, 2023   25,982    -   $6.57    1.35 
                     
Exercisable, June 30, 2023   25,982    -   $6.57    1.35 

 

NOTE 11 - RELATED PARTY TRANSACTIONS

 

Officers and Directors

 

Per Steven Rotman’s Employment agreement dated July 22, 2019, as amended, he is to be paid $125,000 per year in cash, $10,417 per month in shares based on a 20-day average price at a 50% discount to market, $5,000 per month in cash for expenses as well as access to a Company provided vehicle and health and life insurance. During the six months ended June 30, 2023, the Company expensed approximately $210,000 related to this employment agreement. As of June 30, 2023, the Company had a stock subscription payable balance of $730,954, or approximately 2,491,000 shares to be issued in the future and $213,155 of reimbursable expenses payable and $116,403 of unpaid salary related to this party.

 

The Board of Directors authorized their board fees for 2021 be paid in common stock of the Company. Included in stock subscription payable at June 30, 2023 and December 31, 2022 is 100,000 shares valued at $291,000, of which 20,000 shares valued at $58,200 is included in Steven Rotman’s balance above.

 

Blue Oar Consulting, Inc.

 

This entity is owned by Gregory Rotman, who is the son of the Company’s CEO, Steven Rotman. Blue Oar provides business consulting services to the Company. In exchange for such services, the Company has entered into a consulting agreement with the related party entity.

 

Per the consulting agreement, Blue Oar is to be paid $15,000 per month in cash for expenses, and $12,500 per month to be paid in shares based on a 20-day average at a 50% discount to market. During the six months ended June 30, 2023, the Company expensed approximately $224,000 related to the consulting agreement. As of June 30, 2023, the Company had a stock subscription payable balance of $764,147, or approximately 2,934,000 shares.

 

Related Party Advances

 

As of June 30, 2023, Gregory Rotman and Steven Rotman advanced the Company funds totaling $269,659 and $30,225, respectively. The advances are due on demand as repayment terms have not yet been finalized.

 

Designcenters.com

 

This entity is owned by Jamie Rotman, who is the daughter of the Company’s CEO, Steven Rotman. Designcenters.com (“Design”) provided bookkeeping and management services to the Company through July 2019. In exchange for such services, the Company had entered into a consulting agreement with the related party entity. As of June 30, 2023, the Company had a stock subscription payable balance of $42,000, for approximately 8,500 shares related to this party for services incurred and expensed in 2019.

 

21

 

 

NOTE 12 - COMMITMENTS

 

Employment and Consulting Agreements

 

The Company has entered into employment and consulting agreements with certain of our officers, employees, and affiliates. For employees, payment and benefits would become payable in the event of termination by us for any reason other than cause, or upon change in control of our Company, or by the employee for good reason.

 

There is currently one employment agreement in place with the CEO, Steven Rotman. See compensation terms in Note 11.

 

During the six months ended June 30, 2023, the Company entered into various service agreements with consultants for financial reporting, advisory, and compliance services.

 

Litigation

 

From time to time, the Company is party to certain legal proceedings that arise in the ordinary course and are incidental to our business. Future events or circumstances, currently unknown to management, will determine whether the resolution of pending or threatened litigation or claims will ultimately have a material effect on our consolidated financial position, liquidity or results of operations in any future reporting periods.

 

EMA Financial

 

On February 19, 2019, EMA Financial, Inc. filed a lawsuit in the Southern District of New York against the Company. The lawsuit alleged various breaches of an underlying convertible promissory note and stock purchase agreement and sought four claims for relief: (i) specific performance to enforce a stock conversion and contractual obligations; (ii) breach of contract; (iii) permanent injunction to enforce the stock conversion and contractual obligations; and (iv) legal fees and costs of the litigation. The complaint was filed with a motion seeking: (i) a preliminary injunction seeking an immediate resolution of the case through the stock conversion; (ii) a consolidation of the trial with the preliminary injunctive hearing; and (iii) summary judgment on the first and third claims for relief.

 

The Company filed an opposition to the motion and upon oral argument the motion for injunctive relief was denied. The Court issued a decision permitting a motion for summary judgment to proceed and permitted the Company the opportunity to supplement its opposition papers together with the plaintiff who was also provided opportunity to submit reply papers. On April 5, 2019, the Company filed the opposition papers as well as a motion to dismiss the first and third causes of action in the complaint. On March 13, 2020, the Court granted the Company’s motion dismissing the first and third claims for relief and denied the motion for summary judgment as moot.

 

The Company subsequently filed an amended answer with counterclaims. The affirmative defenses if granted collectively preclude the relief sought. In addition, Vystar filed counterclaims asserting: (a) violation of 10(b)(5) of the Securities and Exchange Act; (b) violation of Section 15(a)(1) of the Exchange Act (failure to register as a broker-dealer); (c) pursuant to the Uniform Declaratory Judgment Act, 28 U.S.C. §§ 2201, the Company requests the Court to declare: (i) pursuant to Delaware law, the underlying agreements are unconscionable; (ii) the underlying agreements are unenforceable and/or portions are unenforceable, such as the liquidated damages sections; (iii) to the extent the agreement is enforceable, Vystar in good faith requests the Court to declare the legal fee provisions of the agreements be mutual (d) unjust enrichment; (e) breach of contract (in the alternative); and (f) attorneys’ fees.

 

On June 10, 2020, EMA filed a motion for summary judgment as to its remaining claims for relief and a motion to dismiss the Company’s affirmative defenses and counterclaims. The Company opposed the motion on July 10, 2020, and the same was fully submitted to the Court on July 28, 2020. On March 29, 2021, the Court issued a decision granting in part and denying in part the motion. Specifically, the Court granted that part of the motion seeking summary judgment and dismissal on the Company’s affirmative defense and counterclaim regarding Sections 15(a)/29(b) of the Exchange Act. Two weeks later the Company filed a motion for reconsideration as to the dismissal portion of the order, or, for the alternative, a motion for certification for the right to file a petition to the Second Circuit Court of Appeals on the issue. The Court denied the motion for reconsideration and certification. Subsequently, fact discovery has been completed and on June 24, 2022 both parties submitted competing motions for summary judgment.

 

22

 

 

On EMA seeks summary judgment on its breach of contract and attorneys’ fees claims, specifically seeking damages in the amount of $1,820,000 with 24% interest premised on the argument it was entitled to effectuate a January 15 and February 5, 2019, notices of conversions. EMA further seeks to dismiss Vystar’s affirmative defenses and counterclaims. Conversely, Vystar filed its motion for summary judgment seeking an order to dismiss the EMA complaint on the grounds: (i) the underlying note was satisfied on December 11, 2018; and (ii) EMA, through multiple breaches of the note, over-converted the note by 36,575,555 shares equating to a request of damages against EMA and in favor of Vystar for $4,802,000, with interest accruing at 24%, and attorneys’ fees. The briefing by the parties was fully submitted on July 29, 2022.

 

On January 6, 2023, the Court issued a series of preliminary rulings based upon the parties’ respective summary judgment motions. Those rulings narrowed the outstanding issues (and claims) to only the parties’ breach of contract claim and counterclaim (and affirmative defenses) regarding the conversion process. Of particular importance, the Court found EMA breached the note by failing to effectuate the conversions in the manner outlined by the controlling note. The Court further found the principal balance at issue was $80,000, interest accrued from the date set in the note and default interest, to the extent applicable, was to accrue at the default rate from September 2018, forward. The Court left undecided whether EMA’s breach of the note was material, whether affirmative defenses as previously raised by the parties were applicable to each parties’ contractual claim, and a damages analysis associated with the same. The Court then requested a supplemental briefing as to the issues of materiality, liability and damages. The issues were fully briefed and submitted on February 24 and March 15, 2023. The parties await a final decision from the Court.

 

NOTE 13 - MAJOR CUSTOMERS AND VENDORS

 

Major customers and vendors are defined as a customer or vendor from which the Company derives at least 10% of its revenue and cost of revenue, respectively.

 

During the six months ended June 30, 2023, the Company made approximately 21% of its sales to one customer. Included in accounts payable is $1,429 at June 30, 2023 due to the customer for returned merchandise.

 

During the six months ended June 30, 2022, Rotmans made approximately 16% of its purchases from one major vendor. Rotmans owed its major vendor approximately $81,000 at June 30, 2022.

 

NOTE 14 - INCOME TAXES

 

The provision (benefit) for income taxes for the three months ended June 30, 2023 and 2022 assumes a 21% effective tax rate for federal income taxes. A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income taxes is as follows:

 

   2023   2022 
   Six Months Ended 
   June 30, 
   2023   2022 
         
Federal statutory income tax rate   (21.0)%   (21.0)%
           
Change in valuation allowance on net operating loss carryforwards   21.0    21.0 
           
Effective income tax rate   0.0%   0.0%

 

23

 

 

Deferred tax assets as of June 30, 2023 and December 31, 2022 are as follows:

 

   2023   2022 
         
NOL carryforwards  $8,350,000   $8,300,000 
           
Less valuation allowance   (8,350,000)   (8,300,000)
           
Deferred tax assets  $-   $- 

 

Deferred taxes are caused primarily by net operating loss carryforwards. U.S. Tax Legislation enacted in 2017 (the “TCJA”) has significantly changed certain aspects of U.S. federal income taxation. Net Operating Losses (“NOLs”) generated in 2017 and prior years can be carried forward for 20 years. NOLs generated in 2018 – 2020, as enacted by the CARES Act, can be carried forward indefinitely. However, NOLs generated after 2020 can also carried forward indefinitely but limited to 80% of taxable income.

 

For federal income tax purposes, the Company has a net operating loss carryforward of approximately $39,800,000 as of June 30, 2023, of which approximately $18,400,000 expires beginning in 2024 and $21,400,000 which can be carried forward indefinitely. For state income tax purposes, the Company has a net operating loss carryforward of approximately $18,400,000 and $21,200,000 as of June 30, 2023 in Georgia and Massachusetts, respectively, which expires beginning in 2038.

 

In addition, as of June 30, 2023, Rotmans has a net operating loss carryforward of approximately $5,500,000 for federal income tax purposes of which $1,800,000 expires beginning in 2029 and $3,700,000 can be carried forward indefinitely. Rotmans has a state operating loss carryforward of approximately $4,600,000 which expires beginning in 2038.

 

Pursuant to Internal Revenue Code Section 382, the future realization of our net operating loss carryforwards to offset future taxable income may be subject to an annual limitation as a result of ownership changes that may have occurred previously or that could occur in the future.

 

NOTE 15 - DISCONTINUED OPERATIONS

 

Rotmans closed its showroom on December 14, 2022. The Company has accounted for the closing as discontinued operations in accordance with ASC No. 205-20, Discontinued Operations. The results of operations are reported as discontinued operations in 2023 and 2022. The assets and liabilities have been reported in the condensed consolidated balance sheets as assets and liabilities of discontinued operations.

 

24

 

 

The loss from discontinued operations for the three and six months ended June 30, 2023 and 2022 are as follows:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Revenue  $50,000   $3,150,710   $157,479   $6,866,448 
                     
Cost of revenue   -    1,442,022    122,650    3,064,071 
                     
Gross profit   50,000    1,708,688    34,829    3,802,377 
                     
Operating expenses:                    
Salaries, wages and benefits   101,954    726,436    366,625    1,575,580 
Agent fees   -    327,007    -    745,186 
Professional fees   23,099    111,326    121,692    167,916 
Advertising   (824)   306,103    66,456    593,357 
Rent   181,061    177,184    360,843    352,518 
Service charges   319    82,635    20,919    188,038 
Depreciation and amortization   4,640    115,461    9,824    230,922 
Other operating   124,733    367,469    651,238    820,797 
                     
Total operating expenses   434,982    2,213,621    1,597,597    4,674,314 
                     
Loss from operations   (384,982)   (504,933)   (1,562,768)   (871,937)
                     
Other income (expense):                    
Interest expense   (76,737)   (95,688)   (160,439)   (190,282)
Gain on settlement of debt, net   -    -    39,770    - 
Gain on sale of property and equipment   213,776    -    213,776    - 
Other income   26,594    33,752    32,290    67,704 
                     
Total other income (expense), net   163,633    (61,936)   125,397    (122,578)
                     
Net loss from discontinued operations  $

(221,349

)  $

(566,869

)  $

(1,437,371

)  $

(994,515

)

 

25

 

 

Details of the balance sheet items for discontinued operations as are as follows:

 

   2023   2022 
         
Current assets:          
Cash  $131,112   $123,325 
Accounts receivable   187,342    1,853,972 
Other receivables   33,334    684,775 
Inventories   -    76,379 
Prepaid expenses and other   399,616    288,520 
           
Total current assets  $751,404   $3,026,971 
           
Non-current assets:          
Property and equipment, net  $114,889   $490,420 
Operating lease right-of-use assets, net   6,642,285    7,008,276 
Other assets   5,274    5,274 
           
Total non-current assets  $6,762,448   $7,503,970 
           
Current liabilities:          
Accounts payable  $254,937   $339,426 
Accrued expenses   125,525    726,410 
Operating lease liabilities - current maturities   811,000    737,000 
Finance lease liabilities - current maturities   181,000    119,000 
Related party debt - current maturities   22,518    406,753 
           
Total current liabilities  $1,394,980   $2,328,589 
           
Non-current liabilities:          
Operating lease liabilities, net of current maturities  $4,807,453   $5,189,140 
Finance lease liabilities, net of current maturities   262,527    324,527 
           
Total non-current liabilities  $5,069,980   $5,513,667 

 

The consolidated statements of cash flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Included in adjustments to reconcile net loss to net cash used in operating activities for the six months ended June 30, 2023 and 2022 are the following discontinued operations items:

 

   2023   2022 
         
Depreciation  $9,824   $106,756 
Bad debts   4,537    3,461 
Amortization of intangible assets   -    124,166 
Noncash lease expense   73,408    153,016 
Gain on settlement of debt, net   (39,770)   - 

 

NOTE 16 - SUBSEQUENT EVENTS

 

Rotmans facilities lease was amended on August 10, 2023. Beginning in September 2023, in addition to the monthly base rent, Rotmans will be responsible for the base year heating costs of $9,833 per month with any annual increase over the base year due within thirty days of receipt. A supplementary payment of $10,106 for insurance costs was made with the amendment. Rotmans also assumed liability for roof repairs for a specified building within the facilities; subleases will be deemed approved by the lessor unless notified to the contrary within ten days, and the lessor has the option, with a six-month notice, to terminate the lease after December 31, 2028. Simultaneously, two subleases were approved with occupancy scheduled to begin shortly. Base sublease rent in the aggregate totals $30,993 per month with annual increases based on the consumer price index. Each lease term is at least five years.

 

26

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

OVERVIEW

 

This analysis of our results of operations should be read in conjunction with the accompanying financial statements. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Statements that are predictive in nature and that depend upon or refer to future events or conditions are forward-looking statements. Although we believe that these statements are based upon reasonable expectations, we can give no assurance that projections will be achieved. Please refer to the discussion of forward-looking statements included in Part I of this Report.

 

About RxAir

 

RxAir promotes a healthy lifestyle through the use of its innovative, patented ViraTech air purification technology, thereby improving the quality of life of each and every customer. Independently tested by the U.S. Environmental Protection Agency (“EPA”) and U.S. Food and Drug Administration (“FDA”) certified laboratories, the RxAir has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and volatile organic compounds (“VOCs”). The RxAir uses high-intensity germicidal UV lamps that destroy bacteria and viruses instead of just trapping them, setting it apart from ordinary air filtration units. RxAir® and ViraTech® are registered trademarks of Vystar Corp. For more information, visit http://www.RxAir.com.

 

The Company’s RxAir product line use 48 inches of high-intensity germicidal UV lamps that destroy bacteria, viruses and other germs instead of just trapping them, setting it apart from ordinary air filtration units. RxAir is one of the few UV air purifiers that have been proven in independent EPA- and FDA- certified testing laboratories to destroy on the first pass 99.6% of harmful airborne viruses and bacteria. In addition to inactivating airborne viruses that cause influenza (flu) and colds, RxAir’s device disarms the airborne pathogens that cause MRSA (staph), strep (whooping cough), tuberculosis (TB), measles, pneumonia and a myriad of other antibiotic-resistant and viral infections.

 

The RxAir product line includes:

 

  RxAir™ Residential Filterless Air Purifier
  RX400 ™ FDA cleared Class II Filterless Air Purifier
  RX3000™ Commercial FDA cleared Class II Air Purifier

 

Vystar produces the RxAir product line with a new world-class manufacturer and an expert U.S. engineer with a full understanding of the RxAir technology. Vystar sells RxAir residential and commercial units through multiple distributors and the Company’s website. Once distribution channels are firmly established, Vystar expects the air purification products will produce margins of approximately 70%.

 

Vystar’s Board of Directors have approved preliminary plans to spin off the RxAir, Vytex and FEC product lines into a separate legal entity which Vystar intends to take public. Vystar anticipates retaining approximately 10% of the shares in the new entity and will distribute the remaining ownership percentage to Vystar shareholders. This plan is expected to be executed in late 2023.

 

About Vytex

 

Vytex is a multi-patented latex raw material in which the allergy causing proteins are reduced to a level that falls at or below detection based on ASTM approved test methods. Vytex has been available as a raw material commercially for over fifteen years and through that time has a group of manufacturers who use it in end products such as electrical gloves, condoms, adhesives, etc. Latex has been trading below $1,000 a metric tonne for some time now, hence a large oversupply heading into the winter. Synthetics are dominating the market.

 

Ironically, most use Vytex as it’s better for their manufacturing process as an easier to use raw material and not for protein properties. As of mid-2020 Vystar and the Indian Rubber Manufacturers Research Association’s (“IRMRA”) had been actively collaborating to develop viscoelastic deproteinized natural rubber (DPNR) variants having properties for expanding applications in specific new arenas such as green tires, biodegradable and other unique bioelastoplast product lines that desire a new approach. Additionally, this research, while slowed by the COVID-19 pandemic, showed attributes with extra low ammonia offerings that are desired.

 

Towards the end of 2020, Vystar entered into a Market Development and Distribution Agreement with Corrie MacColl, Ltd. (“CMC Global”) to produce, develop and manage the Vytex product and supply lines. This agreement allows Vystar to expand the market for its Natural Rubber Latex products and has garnered much attention across a broad range of industries including liquid Vytex as well as the newly developed dry rubber Vytex. As of the date of this report, CMC Global has provided numerous opportunities that are in a trial basis or moving towards manufacturing trials in industries that use a significant amount of natural rubber latex, hence Vytex that now includes production size trial runs in a large dipped product consumer line starting late 2022. Additionally Vystar now has a testing supply of Vytex dry rubber for larger trials. The success of early trials and the shipping crisis has led to broader spectrum of manufacturers combining the potential of Cameroon production with strategically placed contract manufacturers based on geographical needs including the North American maket. Also Vystar research has shown great strides in specializing liquid Vytex (ultra low protein latex, ULPL) to meet the immediate needs of customers such as low or no nitrosamine and others (discussed in the presentation below available in the pdf) and additional patents have been proposed to cover these findings. Research into dry rubber continues at a moderate pace as tire companies seek out alternatives to synthetics.

 

27

 

 

Vytex researcher Dr. Ranjit Matthan and CMC Global Director John Heath presented at The International Latex Conference which was held virtually July 20 to 22, 2021 and offered a plenary session entitled “Innovations and Sustainability in Natural Rubber Latex - The New Paradigm.” The presentation discussed the dramatic effect the COVID-19 pandemic has had on the natural rubber supply chain, and how the industry is reacting the new economic circumstances; including strategy and policy shifts in supply chain management and restoring greater geographic diversification of latex processing and product manufacturing. The R&D association with IRMRA promises quicker laboratory and field-based testing and evaluations downstream. At Vystar, the recalibrated sustainability programme (FSC, nitrosamines & ammonia free, ultralow proteins, no SVHC and green carbon neutrality) emphasize certifications with Corrie MacColl market reach facilitating faster rollouts. Nontraditional/non Hevea brasiliensis based production efforts are likely to continue to face new penetration and high cost-benefit acceptance challenges in this decade. A PDF of the full presentation is available on vytex.com.

 

Additionally, in August 2021, Dr. Matthan presented new data to the Automotive Tyre Manufacturers’ Association including Vytex dry rubber.

 

About FEC

 

Vystar is looking to Fluid Energy as it moves forward in its quest for a cleaner and safer environment. The Company is planning to improve its air purifying by using the ultrasonic technology of Fluid Energy and combining it with its leading UV-C technology. The designs and prototypes are in development. This ultrasonic technology is applied into water products with the same goal. We have working prototypes for our water product targets that have tested beyond expectation for bacterial killing and flow metering. We will begin soon evaluating our ability to eradicate hard water pollution that fouls pools, fountains, and pumps. These products will move us toward living more safely and cleanly in our environment.

 

RESULTS OF OPERATIONS

 

Comparison of the Three Months Ended June 30, 2023 with the Three Months Ended June 30, 2022

 

   Three Months Ended June 30, 
   2023   2022   $ Change   % Change 
   CONSOLIDATED 
                 
Revenue  $36,126   $45,323   $(9,197)   -20.3%
                     
Cost of revenue   5,913    25,942    (20,029)   -77.2%
                     
Gross profit   30,213    19,381    10,832    55.9%
                     
Operating expenses:                    
Salaries, wages and benefits   74,282    59,495    14,787    24.9%
Share-based compensation   107,204    338,857    (231,653)   -68.4%
Professional fees   6,269    22,146    (15,877)   -71.7%
Advertising   3,561    7,981    (4,420)   -55.4%
Rent   20,001    -    20,001    100.0%
Service charges   3,568    2,437    1,131    46.4%
Depreciation and amortization   18,819    35,119    (16,300)   -46.4%
Other operating   85,446    140,213    (54,767)   -39.1%
                     
Total operating expenses   319,150    606,248    (287,098)   -47.4%
                     
Loss from operations   (288,937)   (586,867)   297,930    -50.8%
                     
Other income (expense):                    
Interest expense   (11,181)   (111,489)   100,308    -90.0%
Change in fair value of derivative liabilities   -    1,463,000    (1,463,000)   -100.0%
Gain on settlement of debt, net   -    230,820    (230,820)   -100.0%
                     
Total other income (expense), net   (11,181)   1,582,331    (1,593,512)   -100.7%
                     
Net income (loss) from continuing operations   (300,118)   995,464    (1,295,582)   -130.1%
                     
Discontinued operations:                    
Loss from operations   (221,349)   (566,869)   345,520    -61.0%
                     
Net income (loss)   (521,467)   428,595    (950,062)   -221.7%
                     
Net loss attributable to noncontrolling interest   92,967    238,084    (145,117)   -61.0%
                     
Net loss attributable to Vystar  $(428,500)  $666,679   $(1,095,179)   -164.3%

 

28

 

 

Revenues

 

Revenues for the three months ended June 30, 2023 and 2022 were $36,126 and $45,323, respectively, for a decrease of $9,197 or 20.3%. The decrease in revenues can be attributed to a reduction in discretionary consumer spending due to rising costs.

 

The Company reported gross profit of $30,213 for the three-month period ended June 30, 2023 compared to gross profit of $19,381 for the three-month period ended June 30, 2022, an increase of $10,832 or 55.9%. The increase in gross profit is attributable to the sale of slow-moving inventory items and the overall mix of products sold.

 

The cost of revenue for the three months ended June 30, 2023 and 2022 was $5,913 and $25,942, respectively, a decrease of $20,029 or 77.2%. The decrease is attributable to higher reserves being maintained on slow-moving inventory which directly offsets the carrying cost of the products sold.

 

Operating Expenses

 

The Company’s operating expenses consist primarily of compensation and support costs for management and administrative staff, and for other general and administrative costs, including professional fees related to accounting, finance, and legal services as well as advertising, rent and other operating expenses. The Company’s operating expenses were $319,150 and $606,248 for the three months ended June 30, 2023 and 2022, respectively, a decrease of $287,098 or 47.4%. The decrease was partly due to a reduction in share-based compensation for legal and supplemental consulting services.

 

Other Income (Expense)

 

Other expense for the three months ended June 30, 2023 was $11,181 which consisted of interest expense. This compares to other income of $1,582,331 for the three months ended June 30, 2022, which consisted of change in fair value of derivative liabilities of $1,463,000, gain on settlement of debt, net of $230,820 and interest expense of $111,489.

 

Discontinued Operations

 

Loss from discontinued operations for the three months ended June 30, 2023 and 2022 was $221,349 and $566,869, respectively, for a decrease of $345,520 or 61%. The loss in 2023 included post-closing store costs and fixed costs which exceeded revenues earned from inventory sales. The loss in 2022 reflected decreased revenues due to rising inflation which resulted in changes in discretionary consumer spending.

 

Net Income (Loss)

 

Net loss was $521,467 for the three months ended June 30, 2023 compared to net income of $428,595 for the three months ended June 30, 2022, a decrease of $950,062 or 221.7%. Net income in the quarter ended June 30, 2022 was primarily due to the change in fair value of derivative liabilities of $1,463,000 upon settlement of shareholder notes payable and related party debt which contained embedded conversion features.

 

29

 

 

RESULTS OF OPERATIONS

 

Comparison of the Six Months Ended June 30, 2023 with the Six Months Ended June 30, 2022

 

   Six Months Ended June 30, 
   2023   2022   $ Change   % Change 
   CONSOLIDATED 
                 
Revenue  $446,033   $168,843   $277,190    164.2%
                     
Cost of revenue   82,611    64,167    18,444    28.7%
                     
Gross profit   363,422    104,676    258,746    247.2%
                     
Operating expenses:                    
Salaries, wages and benefits   129,211    118,833    10,378    8.7%
Share-based compensation   246,114    476,805    (230,691)   -48.4%
Professional fees   61,711    154,959    (93,248)   -60.2%
Advertising   10,226    14,215    (3,989)   -28.1%
Rent   40,002    8,393    31,609    376.6%
Service charges   4,372    4,206    166    3.9%
Depreciation and amortization   37,638    70,238    (32,600)   -46.4%
Other operating   173,802    342,499    (168,697)   -49.3%
                     
Total operating expenses   703,076    1,190,148    (487,072)   -40.9%
                     
Loss from operations   (339,654)   (1,085,472)   745,818    -68.7%
                     
Other income (expense):                    
Interest expense   (21,518)   (196,204)   174,686    -89.0%
Change in fair value of derivative liabilities   -    1,520,000    (1,520,000)   -100.0%
Gain on settlement of debt, net   -    230,820    (230,820)   -100.0%
                     
Total other income (expense), net   (21,518)   1,554,616    (1,576,134)   -101.4%
                     
Net income (loss) from continuing operations   (361,172)   469,144    (830,316)   -177.0%
                     
Discontinued operations:                    
Loss from operations   (1,437,371)   (994,515)   (442,856)   44.5%
                     
Net loss   (1,798,543)   (525,371)   (1,273,172)   242.3%
                     
Net loss attributable to noncontrolling interest   603,696    417,696    186,000    44.5%
                     
Net loss attributable to Vystar  $(1,194,847)  $(107,675)  $(1,087,172)   1009.7%

 

Revenues

 

Revenues for the six months ended June 30, 2023 and 2022 were $446,033 and $168,843, respectively, for an increase of $277,190 or 164.2%. The increase in revenues was primarily due to sales to distributors and income recognized upon the satisfaction of the warranty coverage term on RxAir units.

 

The Company reported gross profit of $363,422 for the six-month period ended June 30, 2023 compared to gross profit of $104,676 for the six-month period ended June 30, 2022, an increase of $258,746 or 247.2%. The increase in gross profit is attributable to the income recognized upon the satisfaction of the RxAir warranty coverage term.

 

The cost of revenue for the six months ended June 30, 2023 and 2022 was $82,611 and $64,167, respectively, an increase of $18,444 or 28.7%. The increase is consistent with increased product sales.

 

30

 

 

Operating Expenses

 

The Company’s operating expenses consist primarily of compensation and support costs for management and administrative staff, and for other general and administrative costs, including professional fees related to accounting, finance, and legal services as well as advertising, rent and other operating expenses. The Company’s operating expenses were $703,076 and $1,190,148 for the six months ended June 30, 2023 and 2022, respectively, a decrease of $487,072 or 40.9%. The decrease was partly due to a reduction in share-based compensation for legal and supplemental consulting services and cost cutting of general and administrative expenditures.

 

Other Income (Expense)

 

Other expense for the six months ended June 30, 2023 was $21,518 which consisted of interest expense. This compares to other income of $1,554,616 for the six months ended June 30, 2022, which consisted of change in fair value of derivative liabilities of $1,520,000, gain on settlement of debt, net of $230,820 and interest expense of $196,204.

 

Discontinued Operations

 

Loss from discontinued operations for the six months ended June 30, 2023 and 2022 was $1,437,371 and $994,515, respectively, for an increase of $442,856 or 44.5%. The loss in 2023 included post-closing store costs and fixed costs which exceeded revenues earned from inventory sales.

 

Net Loss

 

Net loss was $1,798,543 and $525,371 for the six months ended June 30, 2023 and 2022, respectively, an increase of $1,273,172 or 242.3%. Net loss in the six months ended June 30, 2022 was significantly reduced by the change in fair value of derivative liabilities of $1,520,000 upon settlement in April 2022 of shareholder convertible notes payable and pending settlement of related party debt in July and September 2022 which contained embedded conversion features.

 

LIQUIDITY AND CAPITAL RESOURCES

 

The Company’s financial statements are prepared using the accrual method of accounting in accordance with U.S. GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. However, we have incurred significant losses and experienced negative cash flow since inception. At June 30, 2023, the Company had cash of $49,517 and a deficit in working capital of approximately $4.4 million. Further, at June 30, 2023, the accumulated deficit amounted to approximately $56.6 million. We use working capital to finance our ongoing operations, and since those operations do not currently cover all of our operating costs, managing working capital is essential to our Company’s future success. Because of this history of losses and financial condition, there is substantial doubt about the Company’s ability to continue as a going concern.

 

A successful transition to profitable operations is dependent upon obtaining sufficient financing to fund the Company’s planned expenses and achieving a level of revenue adequate to support the Company’s cost structure.

 

Management plans to finance future operations using cash on hand, as well as increased revenue from RxAir air purifier sales and Vytex license fees. The Company will also raise capital with common stock subscription issuances.

 

There can be no assurances that we will be able to achieve projected levels of revenue in 2023 and beyond. If we are not able to achieve projected revenue and obtain alternate additional financing of equity or debt, we would need to significantly curtail or reorient operations during 2023, which could have a material adverse effect on our ability to achieve our business objectives, and as a result, may require the Company to file bankruptcy or cease operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions.

 

31

 

 

Our future expenditures will depend on numerous factors, including: the rate at which we can introduce RxAir products and license Vytex NRL raw material and the foam cores made from Vytex to manufacturers and subsequently retailers; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights, along with market acceptance of our products, and services and competing technological developments. As we expand our activities and operations, our cash requirements are expected to increase at a rate consistent with revenue growth after we achieve sustained revenue generation.

 

Sources and Uses of Cash

 

Net cash used in operating activities was $165,192 for the six months ended June 30, 2023 as compared to net cash used in operating activities of $507,409 for the six months ended June 30, 2022. During the six months ended June 30, 2023, cash provided by operations was primarily due to the net loss offset by the increase of assets of discontinued operations, and non-cash related add-back of share-based compensation expense, depreciation and amortization.

 

Net cash provided by investing activities was $579,483 during the six months ended June 30, 2023 and represented proceeds from the sale of property and equipment. There was no cash provided by investing activities during the six months ended June 30, 2022.

 

Net cash used in financing activities was $369,261 during the six months ended June 30, 2023, as compared to net cash provided by financing activities of $426,257 during the six months ended June 30, 2022. During the six months ended June 30, 2023, cash was provided by related party advances of $33,343 which was offset by cash flows used in discontinued operations of $402,604. During the six months ended June 30, 2022, cash was provided by related party advances in the amount of $69,820 and cash flows provided by discontinued operations of $356,437.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that may be reasonably likely to have a current or future material effect on our financial condition, liquidity, or results of operations.

 

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS

 

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Forward-looking statements are, by their very nature, uncertain and risky. These risks and uncertainties include international, national and local general economic and market conditions; demographic changes; our ability to sustain, manage, or forecast growth; product development, introduction and acceptance; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other risks that might be detailed from time to time in our filings with the Securities and Exchange Commission.

 

Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report and in our other reports as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

None

 

32

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

The Company’s Chief Executive Officer and Chief Financial Officer (the “Certifying Officer”) is responsible for establishing and maintaining disclosure controls and procedures for the Company. Although the Certifying Officer has designed such disclosure controls and procedures to ensure that material information is made known to them, particularly during the period in which this report was prepared, certain material weaknesses occurred during the period ended June 30, 2023 and subsequent to period end. The Certifying Officer has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e) (the “Rules”) under the Securities Exchange Act of 1934 (or “Exchange Act”) as of the end of the period covered by this Quarterly Report and is working on improving controls with an outside CPA firm and internal resources.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d - 15(f) under the Securities Exchange Act of 1934). Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes those policies and procedures that: (i) in reasonable detail accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; (iii) provide reasonable assurance that our receipts and expenditures are made in accordance with management authorization; and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting, however well designed and operated, can provide only reasonable, and not absolute, assurance that the controls will prevent or detect misstatements. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there is only the reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions.

 

Management, under the supervision and with the participation of our Chief Executive Officer and our acting Chief Financial Officer, conducted an evaluation of our internal control over financial reporting as of June 30, 2023, based on the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) 2013. Based on our evaluation under the COSO framework, management concluded that our internal control over financial reporting was not effective as of June 30, 2023. Such conclusion was reached based on the following material weaknesses noted by management:

 

  a) We have a lack of segregation of duties due to the small size of the Company.
     
  b) The Company did not maintain reasonable control over records underlying transactions necessary to permit preparation of the Company’s financial statements.
     
  c) Lack of controls that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposal of the Company’s assets that could have a material effect on the financial statements.
     
  d) Lack of a formal CFO position who can devote significant attention to financial reporting resulted in multiple audit adjustments.
     
  e) Lack of a functioning audit committee, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures. Management believes the lack of a functioning audit committee results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future period.

 

Management expects to strengthen internal control during 2023 by developing stronger business and financial processes for accounting for transactions such as warrant/stock issuances, which will enhance internal control for the Company.

 

33

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company is subject to legal proceedings and claims that have not been fully resolved and have arisen in the ordinary course of business. See the discussion of pending legal proceedings in Note 12 of the Notes to Condensed Consolidated Financial Statements.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable

 

ITEM 5. OTHER INFORMATION

 

None

 

ITEM 6. EXHIBITS

 

Exhibit Index

 

Number   Description
     
31.1 *   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1 *   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith

 

34

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  VYSTAR CORPORATION
     
Date: October 26, 2023 By:  /s/ Steven Rotman
    Steven Rotman
    President, Chief Executive Officer, Chief Financial Officer and Director

 

35

 

 

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Steven Rotman, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Vystar Corporation (the “Company”) for the quarter ended June 30, 2023;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;
     
  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and I have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision to ensure that material information relating to the Company is made known to me by others within the Company, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

  5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date: October 26, 2023 By: /s/ Steven Rotman
    President, Chief Executive Officer, and Chief Financial Officer

 

 

 

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Vystar Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Steven Rotman, President, Chief Executive Officer, and Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
     
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Steven Rotman  
Steven Rotman  
President, Chief Executive Officer, and Chief Financial Officer  
   
October 26, 2023  

 

A signed original of this written statement required by Section 906 has been provided to Vystar Corporation and will be retained by Vystar Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of Vystar Corporation, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

 

 

v3.23.3
Cover - shares
6 Months Ended
Jun. 30, 2023
Oct. 26, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 000-53754  
Entity Registrant Name VYSTAR CORPORATION  
Entity Central Index Key 0001308027  
Entity Tax Identification Number 20-2027731  
Entity Incorporation, State or Country Code GA  
Entity Address, Address Line One 725 Southbridge St  
Entity Address, City or Town Worcester  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 01610  
City Area Code (508)  
Local Phone Number 791-9114  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   12,942,592
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 49,517 $ 12,274
Accounts receivable 13,616 12,145
Inventories 69,860 91,724
Prepaid expenses and other 644,884 633,769
Assets of discontinued operations 751,404 3,026,971
Total current assets 1,529,281 3,776,883
Property and equipment, net 119,106 140,886
Other assets:    
Intangible assets, net 138,513 154,371
Inventories, long-term 63,009
Assets of discontinued operations 6,762,448 7,503,970
Total other assets 6,900,961 7,721,350
Total assets 8,549,348 11,639,119
Current liabilities:    
Accounts payable 1,514,098 1,361,483
Accrued expenses 326,588 684,147
Stock subscription payable 1,901,322 1,655,208
Shareholder, convertible and contingently convertible notes payable and accrued interest - current maturities 344,293 336,263
Unearned revenue 44,379 44,479
Liabilities of discontinued operations 1,394,980 2,328,589
Total current liabilities 5,998,721 6,846,262
Long-term liabilities:    
Liabilities of discontinued operations 5,069,980 5,513,667
Total liabilities 11,068,701 12,359,929
Stockholders’ deficit:    
Convertible preferred stock  
Common stock, $0.0001 par value, 500,000,000 shares authorized; 12,942,892 shares issued at June 30, 2023 and December 31, 2022, and 12,942,592 shares outstanding at June 30, 2023 and December 31, 2022, respectively 1,294 1,294
Additional paid-in capital 53,361,925 53,361,925
Accumulated deficit (56,563,715) (55,368,868)
Common stock in treasury, at cost; 300 shares (30) (30)
Total Vystar stockholders’ deficit (3,200,296) (2,005,449)
Noncontrolling interest 680,943 1,284,639
Total stockholders’ deficit (2,519,353) (720,810)
Total liabilities and stockholders’ deficit 8,549,348 11,639,119
Series A Preferred Stock [Member]    
Stockholders’ deficit:    
Convertible preferred stock 1 1
Series B Preferred Stock [Member]    
Stockholders’ deficit:    
Convertible preferred stock 37 37
Series C Preferred Stock [Member]    
Stockholders’ deficit:    
Convertible preferred stock 192 192
Related Party [Member]    
Current liabilities:    
Related party debt - current maturities 173,177 169,552
Related party advances $ 299,884 $ 266,541
v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 12,942,892 12,942,892
Common stock, shares outstanding 12,942,592 12,942,592
Treasury stock, common, shares 300 300
Series A Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.0001 $ 0.0001
Convertible preferred stock, shares authorized 15,000,000 15,000,000
Convertible preferred stock, shares issued 8,698 8,698
Convertible preferred stock, shares outstanding 8,698 8,698
Convertible preferred stock, liquidation preference $ 175,000 $ 170,000
Series B Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.0001 $ 0.0001
Convertible preferred stock, shares authorized 2,500,000 2,500,000
Convertible preferred stock, shares issued 370,969 370,969
Convertible preferred stock, shares outstanding 370,969 370,969
Convertible preferred stock, liquidation preference $ 2,839,000 $ 2,710,000
Series C Preferred Stock [Member]    
Convertible preferred stock, par value $ 0.0001 $ 0.0001
Convertible preferred stock, shares authorized 2,500,000 2,500,000
Convertible preferred stock, shares issued 1,917,973 1,917,973
Convertible preferred stock, shares outstanding 1,917,973 1,917,973
Convertible preferred stock, liquidation preference $ 5,481,000 $ 5,233,000
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue $ 36,126 $ 45,323 $ 446,033 $ 168,843
Cost of revenue 5,913 25,942 82,611 64,167
Gross profit 30,213 19,381 363,422 104,676
Operating expenses:        
Salaries, wages and benefits 74,282 59,495 129,211 118,833
Share-based compensation 107,204 338,857 246,114 476,805
Professional fees 6,269 22,146 61,711 154,959
Advertising 3,561 7,981 10,226 14,215
Rent 20,001 40,002 8,393
Service charges 3,568 2,437 4,372 4,206
Depreciation and amortization 18,819 35,119 37,638 70,238
Other operating 85,446 140,213 173,802 342,499
Total operating expenses 319,150 606,248 703,076 1,190,148
Loss from operations (288,937) (586,867) (339,654) (1,085,472)
Other income (expense):        
Interest expense (11,181) (111,489) (21,518) (196,204)
Change in fair value of derivative liabilities 1,463,000 1,520,000
Gain (loss) on settlement of debt, net 230,820 230,820
Total other income (expense), net (11,181) 1,582,331 (21,518) 1,554,616
Net income (loss) from continuing operations (300,118) 995,464 (361,172) 469,144
Discontinued operations:        
Loss from operations (221,349) (566,869) (1,437,371) (994,515)
Net income (loss) (521,467) 428,595 (1,798,543) (525,371)
Net loss attributable to noncontrolling interest 92,967 238,084 603,696 417,696
Net income (loss) attributable to Vystar $ (428,500) $ 666,679 $ (1,194,847) $ (107,675)
Basic and diluted loss per share:        
Net income (loss) from continuing operations $ (0.02) $ 0.08 $ (0.03) $ 0.04
Net loss from discontinued operations (0.02) (0.04) (0.11) (0.08)
Net loss attributable to noncontrolling interest (0.01) (0.02) (0.05) (0.03)
Net income (loss) attributable to common shareholders $ (0.03) $ 0.05 $ (0.09) $ (0.01)
Basic weighted average number of common shares outstanding 12,942,592 12,942,592 12,942,592 12,942,618
Diluted weighted average number of common shares outstanding 12,942,592 12,942,592 12,942,592 12,942,618
v3.23.3
Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Total Vystar Stockholders Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2021 $ 1 $ 1,294 $ 43,851,510 $ (51,410,516) $ (30) $ (7,557,741) $ 1,657,442 $ (5,900,299)
Balance, shares at Dec. 31, 2021 8,698 12,942,792     (300)      
Net income (loss) (774,354) (774,354) (179,612) (953,966)
Share-based compensation - options         3,691     3,691   3,691
Retirement of common stock                  
Retirement of common stock, shares       (200)            
Balance at Mar. 31, 2022 $ 1 $ 1,294 43,855,201 (52,184,870) $ (30) (8,328,404) 1,477,830 (6,850,574)
Balance, shares at Mar. 31, 2022 8,698 12,942,592     (300)      
Balance at Dec. 31, 2021 $ 1 $ 1,294 43,851,510 (51,410,516) $ (30) (7,557,741) 1,657,442 (5,900,299)
Balance, shares at Dec. 31, 2021 8,698 12,942,792     (300)      
Net income (loss)                   (525,371)
Balance at Jun. 30, 2022 $ 1 $ 1,294 43,858,892 (51,518,191) $ (30) (7,658,034) 1,239,746 (6,418,288)
Balance, shares at Jun. 30, 2022 8,698 12,942,592     (300)      
Balance at Mar. 31, 2022 $ 1 $ 1,294 43,855,201 (52,184,870) $ (30) (8,328,404) 1,477,830 (6,850,574)
Balance, shares at Mar. 31, 2022 8,698 12,942,592     (300)      
Net income (loss) 666,679 666,679 (238,084) 428,595
Share-based compensation - options         3,691     3,691   3,691
Balance at Jun. 30, 2022 $ 1 $ 1,294 43,858,892 (51,518,191) $ (30) (7,658,034) 1,239,746 (6,418,288)
Balance, shares at Jun. 30, 2022 8,698 12,942,592     (300)      
Balance at Dec. 31, 2022 $ 1 $ 37 $ 192 $ 1,294 53,361,925 (55,368,868) $ (30) (2,005,449) 1,284,639 (720,810)
Balance, shares at Dec. 31, 2022 8,698 370,969 1,917,973 12,942,592     (300)      
Net income (loss) (766,347) (766,347) (510,729) (1,277,076)
Balance at Mar. 31, 2023 $ 1 $ 37 $ 192 $ 1,294 53,361,925 (56,135,215) $ (30) (2,771,796) 773,910 (1,997,886)
Balance, shares at Mar. 31, 2023 8,698 370,969 1,917,973 12,942,592     (300)      
Balance at Dec. 31, 2022 $ 1 $ 37 $ 192 $ 1,294 53,361,925 (55,368,868) $ (30) (2,005,449) 1,284,639 (720,810)
Balance, shares at Dec. 31, 2022 8,698 370,969 1,917,973 12,942,592     (300)      
Net income (loss)                   (1,798,543)
Balance at Jun. 30, 2023 $ 1 $ 37 $ 192 $ 1,294 53,361,925 (56,563,715) $ (30) (3,200,296) 680,943 (2,519,353)
Balance, shares at Jun. 30, 2023 8,698 370,969 1,917,973 12,942,592     (300)      
Balance at Mar. 31, 2023 $ 1 $ 37 $ 192 $ 1,294 53,361,925 (56,135,215) $ (30) (2,771,796) 773,910 (1,997,886)
Balance, shares at Mar. 31, 2023 8,698 370,969 1,917,973 12,942,592     (300)      
Net income (loss) (428,500) (428,500) (92,967) (521,467)
Balance at Jun. 30, 2023 $ 1 $ 37 $ 192 $ 1,294 $ 53,361,925 $ (56,563,715) $ (30) $ (3,200,296) $ 680,943 $ (2,519,353)
Balance, shares at Jun. 30, 2023 8,698 370,969 1,917,973 12,942,592     (300)      
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (1,798,543) $ (525,371)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 246,114 476,805
Depreciation 31,604 128,536
Bad debts (recovery) 1,566 (4,039)
Amortization of intangible assets 15,858 172,624
Noncash lease expense 73,408 153,016
Amortization of debt discount 27,083
Change in fair value of derivative liabilities (1,520,000)
Gain on settlement of debt, net (39,770) (230,820)
Gain on sale of property and equipment (213,776)
(Increase) decrease in assets:    
Accounts receivable 1,500 1,833
Inventories 84,873 25,504
Prepaid expenses and other (11,115) 61,645
Assets of discontinued operations 2,278,817 843,994
Increase (decrease) in liabilities:    
Accounts payable 152,615 294,907
Accrued expenses and interest payable (345,903) 77,804
Unearned revenue (100) (33,759)
Liabilities of discontinued operations (642,340) (457,171)
Net cash used in operating activities (165,192) (507,409)
Cash flows from investing activities:    
Cash flows provided by discontinued operations 579,483
Cash flows from financing activities:    
Proceeds from related party advances 33,343 69,820
Cash flows provided by (used in) discontinued operations (402,604) 356,437
Net cash provided by (used in) financing activities (369,261) 426,257
Net increase (decrease) in cash 45,030 (81,152)
Cash - beginning of period 135,599 151,175
Less: cash of discontinued operations (131,112) (53,020)
Cash of continuing operations - end of period 49,517 17,003
Cash paid during the period for:    
Interest 9,863 191,183
Non-cash transactions:    
Rotmans vendor payables paid directly by related party 100,000
Stock subscription payable recorded for consulting and exercise of outstanding options and warrants $ 58,500
v3.23.3
DESCRIPTION OF BUSINESS
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
DESCRIPTION OF BUSINESS

NOTE 1 - DESCRIPTION OF BUSINESS

 

Nature of Business

 

Vystar Corporation (“Vystar”, the “Company”, “we,” “us,” or “our”) is based in Worcester, Massachusetts. The Company uses patented technology to produces a line of innovative air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. Vystar is also the creator and exclusive owner to produce Vytex® Natural Rubber Latex (“NRL”) currently being used primarily in various bedding products. In addition, Vystar has a majority ownership in Murida Furniture Co., Inc. dba Rotmans Furniture (“Rotmans”), formerly one of the largest independent furniture retailers in the U.S.

 

All activities of Rotmans have been included in discontinued operations. Additional disclosure can be found in Note 15.

 

v3.23.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for the fair presentation of the condensed consolidated financial statements have been included. Such adjustments are of a normal, recurring nature. The condensed consolidated financial statements, and the accompanying notes, are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and do not contain certain information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Therefore, the interim condensed consolidated financial statements should be read in conjunction with that Annual Report on Form 10-K.

 

The Company has evaluated subsequent events through the date of the filing of its Form 10-Q with the Securities and Exchange Commission. Other than those events disclosed in Note 16, the Company is not aware of any other significant events that occurred subsequent to the balance sheet date but prior to the filing of this report that would have a material impact on the Company’s financial statements.

 

Basis of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned or controlled operating subsidiaries. All significant intercompany accounts and transactions have been eliminated.

 

Discontinued Operations

 

In accordance with ASC No. 205-20, Discontinued Operations, for all periods presented, the results of operations and related balance sheet items associated with Rotmans are reported in discontinued operations in the accompanying consolidated financial statements. See Note 15 for further details.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets, generally 5 to 10 years, using straight-line and accelerated methods.

 

Expenditures for major renewals and betterments are capitalized, while routine repairs and maintenance are expensed as incurred. When property items are retired or otherwise disposed of, the asset and related reserve accounts are relieved of the cost and accumulated depreciation, respectively, and the resultant gain or loss is reflected in earnings. As of June 30, 2023, the net balance of property and equipment is $119,106 with accumulated depreciation of $223,297. As of December 31, 2022, the net balance of property and equipment is $140,886 with accumulated depreciation of $201,517.

 

 

Unearned Revenue

 

Unearned revenue consists of customer advance payments, deposits on sales of undelivered merchandise and deferred warranty revenue on self-insured stain protection warranty coverage.

 

Changes to unearned revenue during the six months ended June 30, 2023 and 2022 are summarized as follows:

 

   2023   2022 
         
Balance, beginning of the period  $44,479   $79,368 
           
Customer deposits received   -    300 
           
Revenue earned   (100)   (34,058)
           
Balance, end of the period  $44,379   $45,610 

 

Income (Loss) Per Share

 

The Company presents basic and diluted income (loss) per share. For the three and six months ended June 30, 2023 and 2022, common stock equivalents, including stock options and warrants, were anti-dilutive; therefore, the amounts reported for basic and dilutive income (loss) per share were the same. Excluded from the computation of diluted income (loss) per share were options to purchase 25,982 and 265,250 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would be anti-dilutive. Warrants to purchase 43,267 and 38,859 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, were also excluded from the computation of diluted income (loss) per share as their effect would be anti-dilutive. In addition, preferred stock convertible to 25,088,511 and 32,434 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, were excluded from the computation of diluted income (loss) per share as their effect would be anti-dilutive. Both shareholder and Rotman Family contingently convertible notes for the six months ended June 30, 2023 and 2022 were also excluded from the computation of diluted income (loss) per share as no contingencies were met.

 

Revenue

 

Our principal activities from which we generate our revenue are product sales. Revenue is measured based on considerations specified in a contract with a customer. A contract exists when it becomes a legally enforceable agreement with a customer. The contract is based on either the acceptance of standard terms and conditions at the retail store and on the websites for e-commerce customers, or the execution of terms and conditions contracts with retailers and wholesalers. These contracts define each party’s rights, payment terms and other contractual terms and conditions of the sale.

 

Consideration is typically paid prior to shipment via credit card or check when our products are sold direct to consumers, which is typically within 1 to 2 days or approximately 30 days from the time control is transferred when sold to wholesalers, distributors and retailers. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience and, in some circumstances, published credit and financial information pertaining to the customer.

 

 

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for us is transfer of finished goods to our customers. Performance obligations promised in a contract are identified based on the goods that will be transferred to the customer that are both capable of being distinct and are distinct in the context of the contract, whereby the transfer of the goods is separately identifiable from other promises in the contract. We have concluded the sale of finished goods and related shipping and handling are accounted for as the single performance obligation.

 

The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods to the customer. We issue refunds to retail, e-commerce and print media customers, upon request, within 30 days of delivery. We estimate the amount of potential refunds at each reporting period using a portfolio approach of historical data, adjusted for changes in expected customer experience, including seasonality and changes in economic factors. For retailers, distributors and wholesalers, we do not offer a right of return or refund and revenue is recognized at the time products are shipped to customers. Our RxAir units carry a one year warranty. In all cases, judgment is required in estimating these reserves. Actual claims for returns could be materially different from the estimates. As of June 30, 2023 and December 31, 2022, reserves for estimated sales returns totaled $49,000 and $415,000, respectively, and are included in the accompanying condensed consolidated balance sheets as accrued expenses.

 

We recognize revenue when we satisfy a performance obligation in a contract by transferring control over a product to a customer when product is shipped based on fulfillment by the Company. The Company considers fulfillment when it passes all liability at the point of shipping through third party carriers. Delivery fees are charged to customers and are included in revenue in the accompanying condensed consolidated statements of operations and the costs associated with these deliveries are included in revenues as third party carrier are engaged. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of revenue in the accompanying condensed consolidated statements of operations.

 

Advertising Costs

 

Advertising costs, which include television, radio, newspaper, digital and other media advertising, are expensed upon first showing. Advertising costs were approximately $10,000 and $14,000 for the six months ended June 30, 2023 and 2022, respectively.

 

v3.23.3
LIQUIDITY AND GOING CONCERN
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
LIQUIDITY AND GOING CONCERN

NOTE 3 - LIQUIDITY AND GOING CONCERN

 

The Company’s financial statements are prepared using the accrual method of accounting in accordance with U.S. GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. However, the Company has incurred significant losses and experienced negative cash flow since inception. At June 30, 2023, the Company had cash of $49,517 and a deficit in working capital of approximately $4.4 million. Further, at June 30, 2023, the accumulated deficit amounted to approximately $56.6 million. We use working capital to finance our ongoing operations, and since those operations do not currently cover all our operating costs, managing working capital is essential to our Company’s future success. Because of this history of losses and financial condition, there is substantial doubt about the Company’s ability to continue as a going concern.

 

A successful transition to attaining profitable operations is dependent upon obtaining sufficient financing to fund the Company’s planned expenses and achieving a level of revenue adequate to support the Company’s cost structure. Management plans to finance future operations using cash on hand, increased revenue from RxAir air purification units, Vytex license fees and stock issuances to new and existing shareholders.

 

 

There can be no assurances the Company will be able to achieve projected levels of revenue in 2023 and beyond. If the Company is not able to achieve projected revenue and obtain alternate additional financing of equity or debt, the Company would need to significantly curtail or reorient operations during 2023, which could have a material adverse effect on the ability to achieve the business objectives, and as a result, may require the Company to file bankruptcy or cease operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions.

 

The Company’s future expenditures will depend on numerous factors, including: the rate at which the Company can introduce RxAir air purification units and license Vytex NRL raw materials to manufacturers, and subsequently retailers; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance of the Company’s products, services and competing technological developments; the Company’s ability to successfully acquire new customers and maintain a strong brand; and broader economic factors such as interest rates and changes in customer spending patterns. As the Company expands its activities and operations, cash requirements are expected to increase at a rate consistent with revenue growth after the Company has achieved sustained revenue generation.

 

v3.23.3
PROPERTY AND EQUIPMENT
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE 4 - PROPERTY AND EQUIPMENT

 

Property and equipment, net consists of the following:

 

   June 30,   December 31, 
   2023   2022 
         
Tooling and testing equipment  $338,572   $338,572 
Furniture, fixtures and equipment   3,831    3,831 
           
Property and equipment, gross   342,403    342,403 
Accumulated depreciation   (223,297)   (201,517)
           
Property and equipment, net  $119,106   $140,886 

 

Depreciation expense for the six months ended June 30, 2023 and 2022 was $21,780.

 

 

v3.23.3
INTANGIBLE ASSETS
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 5 - INTANGIBLE ASSETS

 

Intangible assets consist of the following:

 

           Amortization 
   June 30,   December 31,   Period 
   2023   2022   (in Years) 
Amortized intangible assets:               
Patents  $361,284   $361,284    6 - 20 
Proprietary technology   13,000    13,000    10 
Tradename and brand   13,000    13,000    5 - 10 
                
Total   387,284    387,284      
Accumulated amortization   (257,843)   (241,985)     
                
Intangible assets, net   129,441    145,299      
Indefinite-lived intangible assets:               
Trademarks   9,072    9,072      
                
Total intangible assets  $138,513   $154,371      

 

Amortization expense for the six months ended June 30, 2023 and 2022 was $15,858 and $48,458, respectively.

 

Estimated future amortization expense for finite-lived intangible assets is as follows:

 

   Amount 
     
Remaining in 2023  $15,858 
2024   31,716 
2025   24,652 
2026   16,032 
2027   16,032 
Thereafter   25,151 
      
Total  $129,441 

 

v3.23.3
LEASES (DISCONTINUED OPERATIONS)
6 Months Ended
Jun. 30, 2023
Leases  
LEASES (DISCONTINUED OPERATIONS)

NOTE 6 - LEASES (DISCONTINUED OPERATIONS)

 

Rotmans leases equipment, a showroom, offices and warehouse facilities. These leases expire at various dates through 2031 and have monthly base rents which range from $800 to $81,000. One of the leases may be terminated early by the lessor at the end of 2028 with a six-month notice.

 

 

The table below presents the lease costs for the three and six months ended June 30, 2023 and 2022:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Operating lease cost  $141,064   $288,134   $306,250   $575,804 
                     
Finance lease cost:                    
                     
Amortization of right-of-use assets   -    39,706    -    84,174 
Interest on lease liabilities   -    6,785    -    14,097 
                     
Total lease cost  $141,064   $334,625   $306,250   $674,075 

 

During the six months ended June 30, 2023 and 2022, the Company recognized sublease income of approximately $14,000 and $68,000, respectively, which in included in discontinued operations in the accompanying condensed consolidated statements of operations.

 

Our leases generally do not provide an implicit rate, and therefore we use our incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of the lease. We used incremental borrowing rates as of the implementation date for operating leases that commenced prior to that date.

 

The following table presents other information related to leases:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Cash paid for amounts included in the measurement of lease liabilities:                    
                     
Operating cash flows used for operating leases  $217,500   $262,004   $463,424   $525,620 
Financing cash flows used for financing leases   -    45,499    -    95,160 
                     
Assets obtained in exchange for operating lease liabilities   -    -    -    - 
                     
Assets obtained in exchange for finance lease liabilities   -    -    -    - 
                     
Weighted average remaining lease term:                    
Operating leases   7.6 years    8.6 years     7.6 years    8.6 years 
Finance leases   2.9 years    3.9 years    2.9 years    3.9 years 
                     
Weighted average discount rate:                    
Operating leases   5.60%   5.60%   5.60%   5.60%
Finance leases   5.16%   5.16%   5.16%   5.16%

 

 

The future minimum lease payments required under operating and financing lease obligations as of June 30, 2023 having initial or remaining non-cancelable lease terms in excess of one year are summarized as follows:

 

   Operating Leases   Finance Leases   Total 
             
Remainder of 2023  $585,927   $139,080   $725,007 
2024   955,272    139,080    1,094,352 
2025   870,000    139,080    1,009,080 
2026   870,000    68,395    938,395 
2027   870,000    -    870,000 
Thereafter   2,682,500    -    2,682,500 
                
Total undiscounted lease liabilities   6,833,699    485,635    7,319,334 
Less: imputed interest   (1,215,246)   (42,108)   (1,257,354)
                
Net lease liabilities  $5,618,453   $443,527   $6,061,980 

 

As of June 30, 2023, Vystar and Rotmans do not have additional operating and finance leases that have not yet commenced.

 

v3.23.3
NOTES PAYABLE AND LOAN FACILITY
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE AND LOAN FACILITY

NOTE 7 - NOTES PAYABLE AND LOAN FACILITY

 

Discontinued Operations

 

Advances/Receivable

 

On May 29, 2020, Rotmans entered into a sale promotion consulting agreement with a national furniture sales event company. Under the agreement, Rotmans appointed the third-party as its exclusive agent to assist with a high-impact sale. Before the sale, the agent advanced the Company funds of approximately $2,300,000 to pay off a bank line of credit and certain other vendors. The agent was reimbursed for the advance from the proceeds of the sale. The initial sales agreement with the agent ended in May 2021. The agreement has been amended numerous times and ended in December 2022. At the conclusion of the agreement, the remaining inventories were transferred to the agent. As of June 30, 2023 and December 31, 2022, a receivable is due from the agent for the inventories in the amount of $187,342 and $1,853,972, respectively, and is included in assets of discontinued operations.

 

Continuing Operations

 

Shareholder, Convertible and Contingently Convertible Notes Payable

 

The following table summarizes shareholder, convertible and contingently convertible notes payable:

 

   June 30,
2023
   December 31,
2022
 
         
Shareholder, convertible and contingently convertible notes  $309,500   $309,500 
Accrued interest   34,793    26,763 
           
Total shareholder notes and accrued interest   344,293    336,263 
           
Less: current maturities   (344,293)   (336,263)
           
Total long-term debt  $-   $- 

 

 

Shareholder Convertible Notes Payable

 

During the year ended December 31, 2021, the Company issued certain contingently convertible promissory notes in varying amounts to existing shareholders which totaled $290,000. The notes are unsecured and bear interest at an annual rate of five percent (5%) from date of issuance. The face amount of the notes represents the amount due at maturity along with the accrued interest. In the event that the spin-off of RxAir does not occur within 2023, the Company will convert these notes into common stock at a conversion price of $1.60. If the spin-off does occur, these notes will convert into RxAir common stock with two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18. All of these notes are outstanding as of June 30, 2023 and December 31, 2022. At the issuance date of these notes, it was determined they contain a beneficial conversion feature amounting to approximately $90,000. As these notes are contingently convertible, the beneficial conversion feature will not be recorded on the consolidated financial statements until the actual conversion occurs.

 

One note remains from the Company’s issuance of shareholder contingently convertible notes payable in 2018 and is (i) unsecured, (ii) bore interest at an annual rate of five percent (5%) from date of issuance, and (iii) is convertible at the Company’s option post April 19, 2018. The note matured one year from issuance and was extended one (1) additional year by the Company. If converted, the note plus accrued interest are convertible into shares of the Company’s common stock at the prior twenty (20) day average closing price with a 50% discount. The outstanding balance as of June 30, 2023 and December 31, 2022 is $19,500. The note matured in January 2020 and continues to accrue interest until settlement. The note is in default and bears interest at an annual rate of eight percent (8%) in arrears. The value of the embedded conversion features on the one remaining note was de minimis at June 30, 2023 and December 31, 2022.

 

Related Party Debt

 

The following table summarizes related party debt:

 

   June 30,   December 31, 
   2023   2022 
         
Rotman Family convertible notes  $5,000   $5,000 
Rotman Family nonconvertible notes   140,000    140,000 
Accrued interest   28,177    24,552 
           
Due to related party   173,177    169,552 
Less: current maturities   (173,177)   (169,552)
           
Due to related party, noncurrent  $-   $- 

 

Rotman Family Convertible Note

 

On August 17, 2021, the Company issued a contingently convertible promissory note totaling $5,000 to Jamie Rotman. The note is unsecured and bears interest at an annual rate of five percent (5%) from date of issuance. The face amount of the note represents the amount due at maturity along with the accrued interest. In the event that the spin-off of RxAir does not occur within one year, the Company will convert the note into common stock at a conversion price of $1.60. If the spin-off does occur, the note will convert into RxAir common stock with two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18. At the issuance date of this note, it was determined to contain a beneficial conversion feature amounting to approximately $2,000. As this note is contingently convertible, the beneficial conversion feature will not be recorded on the consolidated financial statements until the actual conversion occurs. The balance of the note payable including accrued interest to Jamie Rotman is approximately $5,000 at June 30, 2023 and December 31, 2022.

 

 

The following table summarizes the Rotman Family Convertible Note:

 

   Issue Date  Principal Amount   2023   2022 
          Carrying Amount 
          June 30,   December 31, 
   Issue Date  Principal Amount   2023   2022 
Jamie Rotman 5.00% note due August 2023  08/17/21  $5,000   $5,469   $5,344 

 

Rotman Family Nonconvertible Note

 

In connection with the acquisition of 58% of Rotmans, Bernard Rotman was issued a related party note payable in the amount of $140,000. The note bears interest at an annual rate of five percent (5%) and matures four years from issuance. Monthly payments of $2,917 to Bernard Rotman were scheduled to begin six months from issuance until maturity in December 2023. The balance of Bernard Rotman’s note including accrued interest is approximately $168,000 and $164,000 at June 30, 2023 and December 31, 2022, respectively, as no payments have been made to date.

 

The following table summarizes the Rotman Family Nonconvertible Note:

 SCHEDULE OF NOTES PAYABLE

   Issue Date  Principal Amount   2023   2022 
          Carrying Amount 
          June 30,   December 31, 
   Issue Date  Principal Amount   2023   2022 
Bernard Rotman 5.00% note due July 2023  07/18/19  $140,000   $167,708   $164,208 

 

Discontinued Operations Note

 

In April 2022, Blue Oar Consulting, Inc. (“Blue Oar”), an entity wholly owned by Gregory Rotman, advanced Rotmans $500,000 and paid bills totaling $100,000 on Rotmans behalf. Rotmans formalized the advances and issued a promissory note to Blue Oar. The note bore interest at an annual rate of six percent (6%) and required weekly payments of $12,500 until the note and interest is paid in full. The Company also granted Blue Oar a security interest in its inventory. The final principal payment on the note balance was made in April 2023. As of June 30, 2023, unpaid accrued interest on the note totaled $22,518. As of December 31, 2022, the balance of the note payable including accrued interest was approximately $407,000 and is included in liabilities from discontinued operations.

 

v3.23.3
STOCKHOLDERS’ DEFICIT
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 8 - STOCKHOLDERS’ DEFICIT

 

Cumulative Convertible Preferred Stock

 

Series A Preferred Stock

 

On May 2, 2013, the Company began a private placement offering to sell up to 200,000 shares of the Company’s 10% Series A Cumulative Convertible Preferred Stock. Under the terms of the offering, the Company offered to sell up to 200,000 shares of preferred stock at $10 per share for a value of $2,000,000. The preferred stock was convertible at a conversion price of $7.50 per common share at the option of the holder after a nine-month holding period. The conversion price was lowered to $5.00 per common share for those holders who invested an additional $25,000 or more in Vystar’s common stock in the aforementioned September 2014 Private Placement. The preferred shares have full voting rights as if converted and have a fully participating liquidation preference. In the event of a liquidation, dissolution or winding up of the Company, the holders of Series A Preferred Stock shall be entitled to receive an amount equal to the dividends accumulated and unpaid thereon to the date of final distribution to such holders, whether or not declared, without interest, plus a sum equal to $10 per share. As of June 30, 2023 and December 31, 2022, the liquidation preference totals approximately $175,000 and $170,000, respectively.

 

 

As of June 30, 2023, the 8,698 shares of outstanding preferred stock had undeclared dividends of approximately $88,000 and could be converted into 34,135 shares of common stock, at the option of the holder.

 

As of December 31, 2022, the 8,698 shares of outstanding preferred stock had undeclared dividends of approximately $83,000 and could be converted into 33,292 shares of common stock, at the option of the holder.

 

Series B Preferred Stock

 

On April 11, 2022, the Company amended its Articles of Incorporation to add the terms of a 10% Series B Cumulative Convertible Preferred Stock. Under the amendment, the number of shares authorized are 2,500,000. The preferred stock accumulates a 10% per annum dividend and is convertible into 1,000 shares of common stock at the option of the holder after a six-month holding period. The holders of Series B preferred stock have full voting rights as if converted and have a fully participating liquidation preference. In the event of a liquidation, dissolution or winding up of the Company, the holders of Series B Preferred Stock shall be entitled to receive an amount equal to the dividends accumulated and unpaid thereon to the date of final distribution to such holders, whether or not declared, without interest, plus a sum equal to $7 per share. As of June 30, 2023 and December 31, 2022, the liquidation preference totals approximately $2,839,000 and $2,710,000, respectively.

 

As of June 30, 2023, the 370,969 shares of outstanding preferred stock had undeclared dividends of approximately $242,000 and could be converted into 4,055,250 shares of common stock, at the option of the holder.

 

As of December 31, 2022, the 370,969 shares of outstanding preferred stock had undeclared dividends of approximately $108,000 and could be converted into 3,864,261 shares of common stock, at the option of the holder.

 

Series C Preferred Stock

 

On July 8, 2022, the Company amended its Articles of Incorporation to add the terms of a 10% Series C Cumulative Convertible Preferred Stock. Under the amendment, the number of shares authorized are 2,500,000. The preferred stock accumulates a 10% per annum dividend and is convertible into 1,000 shares of common stock at the option of the holder after a six-month holding period. The holders of Series C preferred stock have full voting rights as if converted and have a fully participating liquidation preference. In the event of a liquidation, dissolution or winding up of the Company, the holders of Series C Preferred Stock shall be entitled to receive an amount equal to the dividends accumulated and unpaid thereon to the date of final distribution to such holders, whether or not declared, without interest, plus a sum equal to $2.61 per share. As of June 30, 2023 and December 31, 2022, the liquidation preference totals approximately $5,481,000 and $5,233,000, respectively.

 

As of June 30, 2023, the 1,917,973 shares of outstanding preferred stock had undeclared dividends of approximately $475,000 and could be converted into 20,999,125 shares of common stock, at the option of the holder.

 

As of December 31, 2022, the 1,917,973 shares of outstanding preferred stock had undeclared dividends of approximately $325,000 and could be converted into 20,425,550 shares of common stock, at the option of the holder.

 

Common Stock and Warrants

 

Included in stock subscription payable at June 30, 2023 and December 31, 2022, is $270,000 received under common stock subscription agreements for 180,000 shares during the year ended December 31, 2020.

 

 

Stock Subscription Payable

 

At June 30, 2023 and December 31, 2022, the Company recorded $1,901,322 and $1,655,208, respectively, of stock subscription payable related to common stock to be issued. The following summarizes the activity of stock subscription payable during the period ended June 30, 2023 and December 31, 2022:

 

   Amount   Shares 
         
Balance, January 1, 2022  $1,247,549    605,058 
Additions   659,647    1,552,386 
Issuances   (251,988)   (25,568)
           
Balance, December 31, 2022   1,655,208    2,131,876 
Additions   246,114    3,455,456 
           
Balance, June 30, 2023  $1,901,322    5,587,332 

 

v3.23.3
REVENUES
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
REVENUES

NOTE 9 - REVENUES

 


The following table presents our revenues disaggregated by each major product category and service for the three and six months ended June 30, 2023 and 2022:

 

   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
       % of       % of       % of       % of 
   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales 
Air Purification Units  $20,169    55.8   $38,941    85.9   $423,865    95.0   $142,231    84.2 
Mattresses and Toppers   13,895    38.5    5,126    11.3    19,906    4.5    17,640    10.5 
Other   2,062    5.7    1,256    2.8    2,262    0.5    8,972    5.3 
Net sales  $36,126    100.0   $45,323    100.0   $446,033    100.0   $168,843    100.0 

 

v3.23.3
SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

NOTE 10 - SHARE-BASED COMPENSATION

 

Generally accepted accounting principles require share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income statement based on their fair values at the date of grant, net of estimated forfeitures.

 

In total, the Company recorded $246,114 and $476,805 of stock-based compensation for the six months ended June 30, 2023 and 2022, respectively, including shares to be issued related to consultants and board member stock options and common stock and warrants issued to non-employees. Included in stock subscription payable is accrued stock-based compensation of $1,631,322 and $1,385,208 at June 30, 2023 and December 31, 2022, respectively.

 

The Company used the Black-Scholes option pricing model to estimate the grant-date fair value of option and warrant awards:

 

  Expected Dividend Yield - because the Company does not currently pay dividends, the expected dividend yield is zero;
  Expected Volatility in Stock Price - volatility based on the Company’s trading activity was used to determine expected volatility;
  Risk-free Interest Rate - reflects the average rate on a United States Treasury Bond with a maturity equal to the expected term of the option; and
  Expected Life of Award - because we have minimal experience with the exercise of options or warrants for use in determining the expected life of each award, we used the option or warrant’s contractual term as the expected life.

 

 

In total for the six months ended June 30, 2022, the Company recorded $7,682 of share-based compensation expense related to employee and Board Members’ stock options. The Company did not recognize any such share-based compensation for the six months ended June 30, 2023. There is no unrecognized compensation expense as of June 30, 2023 for non-vested share-based awards to be recognized over a period of less than one year.

 

 

Options

 

During 2004, the Board of Directors of the Company adopted a stock option plan (the “Plan”) and authorized up to 40,000 shares to be issued under the Plan. In April 2009, the Company’s Board of Directors authorized an increase in the number of shares to be issued under the Plan to 100,000 shares and to include the independent Board Members in the Plan in lieu of continuing the previous practice of granting warrants each quarter to independent Board Members for services. At June 30, 2023, there are 22,518 shares of common stock available for issuance under the Plan. In 2014, the Board of Directors adopted an additional stock option plan which provides for an additional 50,000 shares which are all available as of June 30, 2023. In 2019, the Board of Directors adopted an additional stock option plan with provides for 500,000 shares which are all available as of June 30, 2023. The Plan is intended to permit stock options granted to employees to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the Plan that are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options. Stock options are granted at an exercise price equal to the fair market value of the Company’s common stock on the date of grant, typically vest over periods up to 4 years and are typically exercisable up to 10 years.

 

There were no options granted during the six months ended June 30, 2023 and 2022, respectively. Forfeitures are recognized as they occur.

 

The following table summarizes all stock option activity of the Company for the six months ended June 30, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number   Exercise   Contractual 
   of Shares   Price   Life (Years) 
             
Outstanding, December 31, 2022   265,267   $19.54    0.51 
                
Granted   -    -    - 
                
Exercised   -    -    - 
                
Forfeited   (222,000)  $21.95    - 
                
Outstanding, June 30, 2023   43,267   $7.16    0.96 
                
Exercisable, June 30, 2023   43,267   $7.16    0.96 

 

As of June 30, 2023 and 2022, the aggregate intrinsic value of the Company’s outstanding options was minimal. The aggregate intrinsic value will change based on the fair market value of the Company’s common stock.

 

Warrants

 

Warrants are issued to third parties as payment for services, debt financing compensation and conversion and in conjunction with the issuance of common stock. The fair value of each common stock warrant issued for services is estimated on the date of grant using the Black-Scholes option pricing model.

 

 

The following table represents the Company’s warrant activity for the six months ended June 30, 2023:

 

               Weighted 
               Average 
       Weighted   Weighted   Remaining 
   Number   Average   Average   Contractual 
   of Shares   Fair Value   Exercise Price   Life (Years) 
                 
                 
Outstanding, December 31, 2022   37,266    -   $7.57    1.31 
                     
Granted   -        -    -    - 
                     
Exercised   -    -    -    - 
                     
Forfeited   -    -    -    - 
                     
Expired   (11,284)   -   $32.22    - 
                     
Outstanding, June 30, 2023   25,982    -   $6.57    1.35 
                     
Exercisable, June 30, 2023   25,982    -   $6.57    1.35 

 

v3.23.3
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 11 - RELATED PARTY TRANSACTIONS

 

Officers and Directors

 

Per Steven Rotman’s Employment agreement dated July 22, 2019, as amended, he is to be paid $125,000 per year in cash, $10,417 per month in shares based on a 20-day average price at a 50% discount to market, $5,000 per month in cash for expenses as well as access to a Company provided vehicle and health and life insurance. During the six months ended June 30, 2023, the Company expensed approximately $210,000 related to this employment agreement. As of June 30, 2023, the Company had a stock subscription payable balance of $730,954, or approximately 2,491,000 shares to be issued in the future and $213,155 of reimbursable expenses payable and $116,403 of unpaid salary related to this party.

 

The Board of Directors authorized their board fees for 2021 be paid in common stock of the Company. Included in stock subscription payable at June 30, 2023 and December 31, 2022 is 100,000 shares valued at $291,000, of which 20,000 shares valued at $58,200 is included in Steven Rotman’s balance above.

 

Blue Oar Consulting, Inc.

 

This entity is owned by Gregory Rotman, who is the son of the Company’s CEO, Steven Rotman. Blue Oar provides business consulting services to the Company. In exchange for such services, the Company has entered into a consulting agreement with the related party entity.

 

Per the consulting agreement, Blue Oar is to be paid $15,000 per month in cash for expenses, and $12,500 per month to be paid in shares based on a 20-day average at a 50% discount to market. During the six months ended June 30, 2023, the Company expensed approximately $224,000 related to the consulting agreement. As of June 30, 2023, the Company had a stock subscription payable balance of $764,147, or approximately 2,934,000 shares.

 

Related Party Advances

 

As of June 30, 2023, Gregory Rotman and Steven Rotman advanced the Company funds totaling $269,659 and $30,225, respectively. The advances are due on demand as repayment terms have not yet been finalized.

 

Designcenters.com

 

This entity is owned by Jamie Rotman, who is the daughter of the Company’s CEO, Steven Rotman. Designcenters.com (“Design”) provided bookkeeping and management services to the Company through July 2019. In exchange for such services, the Company had entered into a consulting agreement with the related party entity. As of June 30, 2023, the Company had a stock subscription payable balance of $42,000, for approximately 8,500 shares related to this party for services incurred and expensed in 2019.

 

 

v3.23.3
COMMITMENTS
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS

NOTE 12 - COMMITMENTS

 

Employment and Consulting Agreements

 

The Company has entered into employment and consulting agreements with certain of our officers, employees, and affiliates. For employees, payment and benefits would become payable in the event of termination by us for any reason other than cause, or upon change in control of our Company, or by the employee for good reason.

 

There is currently one employment agreement in place with the CEO, Steven Rotman. See compensation terms in Note 11.

 

During the six months ended June 30, 2023, the Company entered into various service agreements with consultants for financial reporting, advisory, and compliance services.

 

Litigation

 

From time to time, the Company is party to certain legal proceedings that arise in the ordinary course and are incidental to our business. Future events or circumstances, currently unknown to management, will determine whether the resolution of pending or threatened litigation or claims will ultimately have a material effect on our consolidated financial position, liquidity or results of operations in any future reporting periods.

 

EMA Financial

 

On February 19, 2019, EMA Financial, Inc. filed a lawsuit in the Southern District of New York against the Company. The lawsuit alleged various breaches of an underlying convertible promissory note and stock purchase agreement and sought four claims for relief: (i) specific performance to enforce a stock conversion and contractual obligations; (ii) breach of contract; (iii) permanent injunction to enforce the stock conversion and contractual obligations; and (iv) legal fees and costs of the litigation. The complaint was filed with a motion seeking: (i) a preliminary injunction seeking an immediate resolution of the case through the stock conversion; (ii) a consolidation of the trial with the preliminary injunctive hearing; and (iii) summary judgment on the first and third claims for relief.

 

The Company filed an opposition to the motion and upon oral argument the motion for injunctive relief was denied. The Court issued a decision permitting a motion for summary judgment to proceed and permitted the Company the opportunity to supplement its opposition papers together with the plaintiff who was also provided opportunity to submit reply papers. On April 5, 2019, the Company filed the opposition papers as well as a motion to dismiss the first and third causes of action in the complaint. On March 13, 2020, the Court granted the Company’s motion dismissing the first and third claims for relief and denied the motion for summary judgment as moot.

 

The Company subsequently filed an amended answer with counterclaims. The affirmative defenses if granted collectively preclude the relief sought. In addition, Vystar filed counterclaims asserting: (a) violation of 10(b)(5) of the Securities and Exchange Act; (b) violation of Section 15(a)(1) of the Exchange Act (failure to register as a broker-dealer); (c) pursuant to the Uniform Declaratory Judgment Act, 28 U.S.C. §§ 2201, the Company requests the Court to declare: (i) pursuant to Delaware law, the underlying agreements are unconscionable; (ii) the underlying agreements are unenforceable and/or portions are unenforceable, such as the liquidated damages sections; (iii) to the extent the agreement is enforceable, Vystar in good faith requests the Court to declare the legal fee provisions of the agreements be mutual (d) unjust enrichment; (e) breach of contract (in the alternative); and (f) attorneys’ fees.

 

On June 10, 2020, EMA filed a motion for summary judgment as to its remaining claims for relief and a motion to dismiss the Company’s affirmative defenses and counterclaims. The Company opposed the motion on July 10, 2020, and the same was fully submitted to the Court on July 28, 2020. On March 29, 2021, the Court issued a decision granting in part and denying in part the motion. Specifically, the Court granted that part of the motion seeking summary judgment and dismissal on the Company’s affirmative defense and counterclaim regarding Sections 15(a)/29(b) of the Exchange Act. Two weeks later the Company filed a motion for reconsideration as to the dismissal portion of the order, or, for the alternative, a motion for certification for the right to file a petition to the Second Circuit Court of Appeals on the issue. The Court denied the motion for reconsideration and certification. Subsequently, fact discovery has been completed and on June 24, 2022 both parties submitted competing motions for summary judgment.

 

 

On EMA seeks summary judgment on its breach of contract and attorneys’ fees claims, specifically seeking damages in the amount of $1,820,000 with 24% interest premised on the argument it was entitled to effectuate a January 15 and February 5, 2019, notices of conversions. EMA further seeks to dismiss Vystar’s affirmative defenses and counterclaims. Conversely, Vystar filed its motion for summary judgment seeking an order to dismiss the EMA complaint on the grounds: (i) the underlying note was satisfied on December 11, 2018; and (ii) EMA, through multiple breaches of the note, over-converted the note by 36,575,555 shares equating to a request of damages against EMA and in favor of Vystar for $4,802,000, with interest accruing at 24%, and attorneys’ fees. The briefing by the parties was fully submitted on July 29, 2022.

 

On January 6, 2023, the Court issued a series of preliminary rulings based upon the parties’ respective summary judgment motions. Those rulings narrowed the outstanding issues (and claims) to only the parties’ breach of contract claim and counterclaim (and affirmative defenses) regarding the conversion process. Of particular importance, the Court found EMA breached the note by failing to effectuate the conversions in the manner outlined by the controlling note. The Court further found the principal balance at issue was $80,000, interest accrued from the date set in the note and default interest, to the extent applicable, was to accrue at the default rate from September 2018, forward. The Court left undecided whether EMA’s breach of the note was material, whether affirmative defenses as previously raised by the parties were applicable to each parties’ contractual claim, and a damages analysis associated with the same. The Court then requested a supplemental briefing as to the issues of materiality, liability and damages. The issues were fully briefed and submitted on February 24 and March 15, 2023. The parties await a final decision from the Court.

 

v3.23.3
MAJOR CUSTOMERS AND VENDORS
6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
MAJOR CUSTOMERS AND VENDORS

NOTE 13 - MAJOR CUSTOMERS AND VENDORS

 

Major customers and vendors are defined as a customer or vendor from which the Company derives at least 10% of its revenue and cost of revenue, respectively.

 

During the six months ended June 30, 2023, the Company made approximately 21% of its sales to one customer. Included in accounts payable is $1,429 at June 30, 2023 due to the customer for returned merchandise.

 

During the six months ended June 30, 2022, Rotmans made approximately 16% of its purchases from one major vendor. Rotmans owed its major vendor approximately $81,000 at June 30, 2022.

 

v3.23.3
INCOME TAXES
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 14 - INCOME TAXES

 

The provision (benefit) for income taxes for the three months ended June 30, 2023 and 2022 assumes a 21% effective tax rate for federal income taxes. A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income taxes is as follows:

 

   2023   2022 
   Six Months Ended 
   June 30, 
   2023   2022 
         
Federal statutory income tax rate   (21.0)%   (21.0)%
           
Change in valuation allowance on net operating loss carryforwards   21.0    21.0 
           
Effective income tax rate   0.0%   0.0%

 

 

Deferred tax assets as of June 30, 2023 and December 31, 2022 are as follows:

 

   2023   2022 
         
NOL carryforwards  $8,350,000   $8,300,000 
           
Less valuation allowance   (8,350,000)   (8,300,000)
           
Deferred tax assets  $-   $- 

 

Deferred taxes are caused primarily by net operating loss carryforwards. U.S. Tax Legislation enacted in 2017 (the “TCJA”) has significantly changed certain aspects of U.S. federal income taxation. Net Operating Losses (“NOLs”) generated in 2017 and prior years can be carried forward for 20 years. NOLs generated in 2018 – 2020, as enacted by the CARES Act, can be carried forward indefinitely. However, NOLs generated after 2020 can also carried forward indefinitely but limited to 80% of taxable income.

 

For federal income tax purposes, the Company has a net operating loss carryforward of approximately $39,800,000 as of June 30, 2023, of which approximately $18,400,000 expires beginning in 2024 and $21,400,000 which can be carried forward indefinitely. For state income tax purposes, the Company has a net operating loss carryforward of approximately $18,400,000 and $21,200,000 as of June 30, 2023 in Georgia and Massachusetts, respectively, which expires beginning in 2038.

 

In addition, as of June 30, 2023, Rotmans has a net operating loss carryforward of approximately $5,500,000 for federal income tax purposes of which $1,800,000 expires beginning in 2029 and $3,700,000 can be carried forward indefinitely. Rotmans has a state operating loss carryforward of approximately $4,600,000 which expires beginning in 2038.

 

Pursuant to Internal Revenue Code Section 382, the future realization of our net operating loss carryforwards to offset future taxable income may be subject to an annual limitation as a result of ownership changes that may have occurred previously or that could occur in the future.

 

v3.23.3
DISCONTINUED OPERATIONS
6 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS

NOTE 15 - DISCONTINUED OPERATIONS

 

Rotmans closed its showroom on December 14, 2022. The Company has accounted for the closing as discontinued operations in accordance with ASC No. 205-20, Discontinued Operations. The results of operations are reported as discontinued operations in 2023 and 2022. The assets and liabilities have been reported in the condensed consolidated balance sheets as assets and liabilities of discontinued operations.

 

 

The loss from discontinued operations for the three and six months ended June 30, 2023 and 2022 are as follows:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Revenue  $50,000   $3,150,710   $157,479   $6,866,448 
                     
Cost of revenue   -    1,442,022    122,650    3,064,071 
                     
Gross profit   50,000    1,708,688    34,829    3,802,377 
                     
Operating expenses:                    
Salaries, wages and benefits   101,954    726,436    366,625    1,575,580 
Agent fees   -    327,007    -    745,186 
Professional fees   23,099    111,326    121,692    167,916 
Advertising   (824)   306,103    66,456    593,357 
Rent   181,061    177,184    360,843    352,518 
Service charges   319    82,635    20,919    188,038 
Depreciation and amortization   4,640    115,461    9,824    230,922 
Other operating   124,733    367,469    651,238    820,797 
                     
Total operating expenses   434,982    2,213,621    1,597,597    4,674,314 
                     
Loss from operations   (384,982)   (504,933)   (1,562,768)   (871,937)
                     
Other income (expense):                    
Interest expense   (76,737)   (95,688)   (160,439)   (190,282)
Gain on settlement of debt, net   -    -    39,770    - 
Gain on sale of property and equipment   213,776    -    213,776    - 
Other income   26,594    33,752    32,290    67,704 
                     
Total other income (expense), net   163,633    (61,936)   125,397    (122,578)
                     
Net loss from discontinued operations  $

(221,349

)  $

(566,869

)  $

(1,437,371

)  $

(994,515

)

 

 

Details of the balance sheet items for discontinued operations as are as follows:

 

   2023   2022 
         
Current assets:          
Cash  $131,112   $123,325 
Accounts receivable   187,342    1,853,972 
Other receivables   33,334    684,775 
Inventories   -    76,379 
Prepaid expenses and other   399,616    288,520 
           
Total current assets  $751,404   $3,026,971 
           
Non-current assets:          
Property and equipment, net  $114,889   $490,420 
Operating lease right-of-use assets, net   6,642,285    7,008,276 
Other assets   5,274    5,274 
           
Total non-current assets  $6,762,448   $7,503,970 
           
Current liabilities:          
Accounts payable  $254,937   $339,426 
Accrued expenses   125,525    726,410 
Operating lease liabilities - current maturities   811,000    737,000 
Finance lease liabilities - current maturities   181,000    119,000 
Related party debt - current maturities   22,518    406,753 
           
Total current liabilities  $1,394,980   $2,328,589 
           
Non-current liabilities:          
Operating lease liabilities, net of current maturities  $4,807,453   $5,189,140 
Finance lease liabilities, net of current maturities   262,527    324,527 
           
Total non-current liabilities  $5,069,980   $5,513,667 

 

The consolidated statements of cash flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Included in adjustments to reconcile net loss to net cash used in operating activities for the six months ended June 30, 2023 and 2022 are the following discontinued operations items:

 

   2023   2022 
         
Depreciation  $9,824   $106,756 
Bad debts   4,537    3,461 
Amortization of intangible assets   -    124,166 
Noncash lease expense   73,408    153,016 
Gain on settlement of debt, net   (39,770)   - 

 

v3.23.3
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 16 - SUBSEQUENT EVENTS

 

Rotmans facilities lease was amended on August 10, 2023. Beginning in September 2023, in addition to the monthly base rent, Rotmans will be responsible for the base year heating costs of $9,833 per month with any annual increase over the base year due within thirty days of receipt. A supplementary payment of $10,106 for insurance costs was made with the amendment. Rotmans also assumed liability for roof repairs for a specified building within the facilities; subleases will be deemed approved by the lessor unless notified to the contrary within ten days, and the lessor has the option, with a six-month notice, to terminate the lease after December 31, 2028. Simultaneously, two subleases were approved with occupancy scheduled to begin shortly. Base sublease rent in the aggregate totals $30,993 per month with annual increases based on the consumer price index. Each lease term is at least five years.

v3.23.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for the fair presentation of the condensed consolidated financial statements have been included. Such adjustments are of a normal, recurring nature. The condensed consolidated financial statements, and the accompanying notes, are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and do not contain certain information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Therefore, the interim condensed consolidated financial statements should be read in conjunction with that Annual Report on Form 10-K.

 

The Company has evaluated subsequent events through the date of the filing of its Form 10-Q with the Securities and Exchange Commission. Other than those events disclosed in Note 16, the Company is not aware of any other significant events that occurred subsequent to the balance sheet date but prior to the filing of this report that would have a material impact on the Company’s financial statements.

 

Basis of Consolidation

Basis of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned or controlled operating subsidiaries. All significant intercompany accounts and transactions have been eliminated.

 

Discontinued Operations

Discontinued Operations

 

In accordance with ASC No. 205-20, Discontinued Operations, for all periods presented, the results of operations and related balance sheet items associated with Rotmans are reported in discontinued operations in the accompanying consolidated financial statements. See Note 15 for further details.

 

Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided over the estimated useful lives of the assets, generally 5 to 10 years, using straight-line and accelerated methods.

 

Expenditures for major renewals and betterments are capitalized, while routine repairs and maintenance are expensed as incurred. When property items are retired or otherwise disposed of, the asset and related reserve accounts are relieved of the cost and accumulated depreciation, respectively, and the resultant gain or loss is reflected in earnings. As of June 30, 2023, the net balance of property and equipment is $119,106 with accumulated depreciation of $223,297. As of December 31, 2022, the net balance of property and equipment is $140,886 with accumulated depreciation of $201,517.

 

 

Unearned Revenue

Unearned Revenue

 

Unearned revenue consists of customer advance payments, deposits on sales of undelivered merchandise and deferred warranty revenue on self-insured stain protection warranty coverage.

 

Changes to unearned revenue during the six months ended June 30, 2023 and 2022 are summarized as follows:

 

   2023   2022 
         
Balance, beginning of the period  $44,479   $79,368 
           
Customer deposits received   -    300 
           
Revenue earned   (100)   (34,058)
           
Balance, end of the period  $44,379   $45,610 

 

Income (Loss) Per Share

Income (Loss) Per Share

 

The Company presents basic and diluted income (loss) per share. For the three and six months ended June 30, 2023 and 2022, common stock equivalents, including stock options and warrants, were anti-dilutive; therefore, the amounts reported for basic and dilutive income (loss) per share were the same. Excluded from the computation of diluted income (loss) per share were options to purchase 25,982 and 265,250 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, as their effect would be anti-dilutive. Warrants to purchase 43,267 and 38,859 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, were also excluded from the computation of diluted income (loss) per share as their effect would be anti-dilutive. In addition, preferred stock convertible to 25,088,511 and 32,434 shares of common stock for the six months ended June 30, 2023 and 2022, respectively, were excluded from the computation of diluted income (loss) per share as their effect would be anti-dilutive. Both shareholder and Rotman Family contingently convertible notes for the six months ended June 30, 2023 and 2022 were also excluded from the computation of diluted income (loss) per share as no contingencies were met.

 

Revenue

Revenue

 

Our principal activities from which we generate our revenue are product sales. Revenue is measured based on considerations specified in a contract with a customer. A contract exists when it becomes a legally enforceable agreement with a customer. The contract is based on either the acceptance of standard terms and conditions at the retail store and on the websites for e-commerce customers, or the execution of terms and conditions contracts with retailers and wholesalers. These contracts define each party’s rights, payment terms and other contractual terms and conditions of the sale.

 

Consideration is typically paid prior to shipment via credit card or check when our products are sold direct to consumers, which is typically within 1 to 2 days or approximately 30 days from the time control is transferred when sold to wholesalers, distributors and retailers. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience and, in some circumstances, published credit and financial information pertaining to the customer.

 

 

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for us is transfer of finished goods to our customers. Performance obligations promised in a contract are identified based on the goods that will be transferred to the customer that are both capable of being distinct and are distinct in the context of the contract, whereby the transfer of the goods is separately identifiable from other promises in the contract. We have concluded the sale of finished goods and related shipping and handling are accounted for as the single performance obligation.

 

The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods to the customer. We issue refunds to retail, e-commerce and print media customers, upon request, within 30 days of delivery. We estimate the amount of potential refunds at each reporting period using a portfolio approach of historical data, adjusted for changes in expected customer experience, including seasonality and changes in economic factors. For retailers, distributors and wholesalers, we do not offer a right of return or refund and revenue is recognized at the time products are shipped to customers. Our RxAir units carry a one year warranty. In all cases, judgment is required in estimating these reserves. Actual claims for returns could be materially different from the estimates. As of June 30, 2023 and December 31, 2022, reserves for estimated sales returns totaled $49,000 and $415,000, respectively, and are included in the accompanying condensed consolidated balance sheets as accrued expenses.

 

We recognize revenue when we satisfy a performance obligation in a contract by transferring control over a product to a customer when product is shipped based on fulfillment by the Company. The Company considers fulfillment when it passes all liability at the point of shipping through third party carriers. Delivery fees are charged to customers and are included in revenue in the accompanying condensed consolidated statements of operations and the costs associated with these deliveries are included in revenues as third party carrier are engaged. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of revenue in the accompanying condensed consolidated statements of operations.

 

Advertising Costs

Advertising Costs

 

Advertising costs, which include television, radio, newspaper, digital and other media advertising, are expensed upon first showing. Advertising costs were approximately $10,000 and $14,000 for the six months ended June 30, 2023 and 2022, respectively.

 

v3.23.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SCHEDULE OF UNEARNED REVENUE

Changes to unearned revenue during the six months ended June 30, 2023 and 2022 are summarized as follows:

 

   2023   2022 
         
Balance, beginning of the period  $44,479   $79,368 
           
Customer deposits received   -    300 
           
Revenue earned   (100)   (34,058)
           
Balance, end of the period  $44,379   $45,610 
v3.23.3
PROPERTY AND EQUIPMENT (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT, NET

Property and equipment, net consists of the following:

 

   June 30,   December 31, 
   2023   2022 
         
Tooling and testing equipment  $338,572   $338,572 
Furniture, fixtures and equipment   3,831    3,831 
           
Property and equipment, gross   342,403    342,403 
Accumulated depreciation   (223,297)   (201,517)
           
Property and equipment, net  $119,106   $140,886 
v3.23.3
INTANGIBLE ASSETS (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

Intangible assets consist of the following:

 

           Amortization 
   June 30,   December 31,   Period 
   2023   2022   (in Years) 
Amortized intangible assets:               
Patents  $361,284   $361,284    6 - 20 
Proprietary technology   13,000    13,000    10 
Tradename and brand   13,000    13,000    5 - 10 
                
Total   387,284    387,284      
Accumulated amortization   (257,843)   (241,985)     
                
Intangible assets, net   129,441    145,299      
Indefinite-lived intangible assets:               
Trademarks   9,072    9,072      
                
Total intangible assets  $138,513   $154,371      
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE

Estimated future amortization expense for finite-lived intangible assets is as follows:

 

   Amount 
     
Remaining in 2023  $15,858 
2024   31,716 
2025   24,652 
2026   16,032 
2027   16,032 
Thereafter   25,151 
      
Total  $129,441 

 

v3.23.3
LEASES (DISCONTINUED OPERATIONS) (Tables)
6 Months Ended
Jun. 30, 2023
Leases  
SCHEDULE OF LEASE COST

The table below presents the lease costs for the three and six months ended June 30, 2023 and 2022:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Operating lease cost  $141,064   $288,134   $306,250   $575,804 
                     
Finance lease cost:                    
                     
Amortization of right-of-use assets   -    39,706    -    84,174 
Interest on lease liabilities   -    6,785    -    14,097 
                     
Total lease cost  $141,064   $334,625   $306,250   $674,075 
SCHEDULE OF OTHER INFORMATION RELATED TO LEASES

The following table presents other information related to leases:

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Cash paid for amounts included in the measurement of lease liabilities:                    
                     
Operating cash flows used for operating leases  $217,500   $262,004   $463,424   $525,620 
Financing cash flows used for financing leases   -    45,499    -    95,160 
                     
Assets obtained in exchange for operating lease liabilities   -    -    -    - 
                     
Assets obtained in exchange for finance lease liabilities   -    -    -    - 
                     
Weighted average remaining lease term:                    
Operating leases   7.6 years    8.6 years     7.6 years    8.6 years 
Finance leases   2.9 years    3.9 years    2.9 years    3.9 years 
                     
Weighted average discount rate:                    
Operating leases   5.60%   5.60%   5.60%   5.60%
Finance leases   5.16%   5.16%   5.16%   5.16%
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS REQUIRED UNDER OPERATING AND FINANCING LEASE OBLIGATIONS

The future minimum lease payments required under operating and financing lease obligations as of June 30, 2023 having initial or remaining non-cancelable lease terms in excess of one year are summarized as follows:

 

   Operating Leases   Finance Leases   Total 
             
Remainder of 2023  $585,927   $139,080   $725,007 
2024   955,272    139,080    1,094,352 
2025   870,000    139,080    1,009,080 
2026   870,000    68,395    938,395 
2027   870,000    -    870,000 
Thereafter   2,682,500    -    2,682,500 
                
Total undiscounted lease liabilities   6,833,699    485,635    7,319,334 
Less: imputed interest   (1,215,246)   (42,108)   (1,257,354)
                
Net lease liabilities  $5,618,453   $443,527   $6,061,980 
v3.23.3
NOTES PAYABLE AND LOAN FACILITY (Tables)
6 Months Ended
Jun. 30, 2023
Short-Term Debt [Line Items]  
SCHEDULE OF LONG - TERM DEBT

The following table summarizes shareholder, convertible and contingently convertible notes payable:

 

   June 30,
2023
   December 31,
2022
 
         
Shareholder, convertible and contingently convertible notes  $309,500   $309,500 
Accrued interest   34,793    26,763 
           
Total shareholder notes and accrued interest   344,293    336,263 
           
Less: current maturities   (344,293)   (336,263)
           
Total long-term debt  $-   $- 
SCHEDULE OF RELATED PARTY DEBT

The following table summarizes related party debt:

 

   June 30,   December 31, 
   2023   2022 
         
Rotman Family convertible notes  $5,000   $5,000 
Rotman Family nonconvertible notes   140,000    140,000 
Accrued interest   28,177    24,552 
           
Due to related party   173,177    169,552 
Less: current maturities   (173,177)   (169,552)
           
Due to related party, noncurrent  $-   $- 
Rotman Family Convertible Notes [Member]  
Short-Term Debt [Line Items]  
SCHEDULE OF NOTES PAYABLE

The following table summarizes the Rotman Family Convertible Note:

 

   Issue Date  Principal Amount   2023   2022 
          Carrying Amount 
          June 30,   December 31, 
   Issue Date  Principal Amount   2023   2022 
Jamie Rotman 5.00% note due August 2023  08/17/21  $5,000   $5,469   $5,344 
Rotman Family Non-convertible Notes [Member]  
Short-Term Debt [Line Items]  
SCHEDULE OF NOTES PAYABLE

The following table summarizes the Rotman Family Nonconvertible Note:

 SCHEDULE OF NOTES PAYABLE

   Issue Date  Principal Amount   2023   2022 
          Carrying Amount 
          June 30,   December 31, 
   Issue Date  Principal Amount   2023   2022 
Bernard Rotman 5.00% note due July 2023  07/18/19  $140,000   $167,708   $164,208 
v3.23.3
STOCKHOLDERS’ DEFICIT (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
SCHEDULE OF ACTIVITY OF STOCK SUBSCRIPTION PAYABLE

 

   Amount   Shares 
         
Balance, January 1, 2022  $1,247,549    605,058 
Additions   659,647    1,552,386 
Issuances   (251,988)   (25,568)
           
Balance, December 31, 2022   1,655,208    2,131,876 
Additions   246,114    3,455,456 
           
Balance, June 30, 2023  $1,901,322    5,587,332 
v3.23.3
REVENUES (Tables)
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF REVENUES


The following table presents our revenues disaggregated by each major product category and service for the three and six months ended June 30, 2023 and 2022:

 

   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
       % of       % of       % of       % of 
   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales   Net Sales 
Air Purification Units  $20,169    55.8   $38,941    85.9   $423,865    95.0   $142,231    84.2 
Mattresses and Toppers   13,895    38.5    5,126    11.3    19,906    4.5    17,640    10.5 
Other   2,062    5.7    1,256    2.8    2,262    0.5    8,972    5.3 
Net sales  $36,126    100.0   $45,323    100.0   $446,033    100.0   $168,843    100.0 

 

v3.23.3
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes all stock option activity of the Company for the six months ended June 30, 2023:

 

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number   Exercise   Contractual 
   of Shares   Price   Life (Years) 
             
Outstanding, December 31, 2022   265,267   $19.54    0.51 
                
Granted   -    -    - 
                
Exercised   -    -    - 
                
Forfeited   (222,000)  $21.95    - 
                
Outstanding, June 30, 2023   43,267   $7.16    0.96 
                
Exercisable, June 30, 2023   43,267   $7.16    0.96 
SCHEDULE OF WARRANT ACTIVITY

The following table represents the Company’s warrant activity for the six months ended June 30, 2023:

 

               Weighted 
               Average 
       Weighted   Weighted   Remaining 
   Number   Average   Average   Contractual 
   of Shares   Fair Value   Exercise Price   Life (Years) 
                 
                 
Outstanding, December 31, 2022   37,266    -   $7.57    1.31 
                     
Granted   -        -    -    - 
                     
Exercised   -    -    -    - 
                     
Forfeited   -    -    -    - 
                     
Expired   (11,284)   -   $32.22    - 
                     
Outstanding, June 30, 2023   25,982    -   $6.57    1.35 
                     
Exercisable, June 30, 2023   25,982    -   $6.57    1.35 
v3.23.3
INCOME TAXES (Tables)
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF PROVISION FOR INCOME TAXES

 

   2023   2022 
   Six Months Ended 
   June 30, 
   2023   2022 
         
Federal statutory income tax rate   (21.0)%   (21.0)%
           
Change in valuation allowance on net operating loss carryforwards   21.0    21.0 
           
Effective income tax rate   0.0%   0.0%
SCHEDULE OF DEFERRED TAX ASSETS

Deferred tax assets as of June 30, 2023 and December 31, 2022 are as follows:

 

   2023   2022 
         
NOL carryforwards  $8,350,000   $8,300,000 
           
Less valuation allowance   (8,350,000)   (8,300,000)
           
Deferred tax assets  $-   $- 
v3.23.3
DISCONTINUED OPERATIONS (Tables)
6 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF DISCONTINUED OPERATIONS

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Revenue  $50,000   $3,150,710   $157,479   $6,866,448 
                     
Cost of revenue   -    1,442,022    122,650    3,064,071 
                     
Gross profit   50,000    1,708,688    34,829    3,802,377 
                     
Operating expenses:                    
Salaries, wages and benefits   101,954    726,436    366,625    1,575,580 
Agent fees   -    327,007    -    745,186 
Professional fees   23,099    111,326    121,692    167,916 
Advertising   (824)   306,103    66,456    593,357 
Rent   181,061    177,184    360,843    352,518 
Service charges   319    82,635    20,919    188,038 
Depreciation and amortization   4,640    115,461    9,824    230,922 
Other operating   124,733    367,469    651,238    820,797 
                     
Total operating expenses   434,982    2,213,621    1,597,597    4,674,314 
                     
Loss from operations   (384,982)   (504,933)   (1,562,768)   (871,937)
                     
Other income (expense):                    
Interest expense   (76,737)   (95,688)   (160,439)   (190,282)
Gain on settlement of debt, net   -    -    39,770    - 
Gain on sale of property and equipment   213,776    -    213,776    - 
Other income   26,594    33,752    32,290    67,704 
                     
Total other income (expense), net   163,633    (61,936)   125,397    (122,578)
                     
Net loss from discontinued operations  $

(221,349

)  $

(566,869

)  $

(1,437,371

)  $

(994,515

)

 

 

Details of the balance sheet items for discontinued operations as are as follows:

 

   2023   2022 
         
Current assets:          
Cash  $131,112   $123,325 
Accounts receivable   187,342    1,853,972 
Other receivables   33,334    684,775 
Inventories   -    76,379 
Prepaid expenses and other   399,616    288,520 
           
Total current assets  $751,404   $3,026,971 
           
Non-current assets:          
Property and equipment, net  $114,889   $490,420 
Operating lease right-of-use assets, net   6,642,285    7,008,276 
Other assets   5,274    5,274 
           
Total non-current assets  $6,762,448   $7,503,970 
           
Current liabilities:          
Accounts payable  $254,937   $339,426 
Accrued expenses   125,525    726,410 
Operating lease liabilities - current maturities   811,000    737,000 
Finance lease liabilities - current maturities   181,000    119,000 
Related party debt - current maturities   22,518    406,753 
           
Total current liabilities  $1,394,980   $2,328,589 
           
Non-current liabilities:          
Operating lease liabilities, net of current maturities  $4,807,453   $5,189,140 
Finance lease liabilities, net of current maturities   262,527    324,527 
           
Total non-current liabilities  $5,069,980   $5,513,667 

 

The consolidated statements of cash flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Included in adjustments to reconcile net loss to net cash used in operating activities for the six months ended June 30, 2023 and 2022 are the following discontinued operations items:

 

   2023   2022 
         
Depreciation  $9,824   $106,756 
Bad debts   4,537    3,461 
Amortization of intangible assets   -    124,166 
Noncash lease expense   73,408    153,016 
Gain on settlement of debt, net   (39,770)   - 
v3.23.3
SCHEDULE OF UNEARNED REVENUE (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Accounting Policies [Abstract]    
Balance, beginning of the period $ 44,479 $ 79,368
Customer deposits received 300
Revenue earned (100) (34,058)
Balance, end of the period $ 44,379 $ 45,610
v3.23.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Property, Plant and Equipment [Line Items]      
Property and equipment $ 119,106   $ 140,886
Accumulated depreciation of property and equipment 223,297   201,517
Reserves for estimated sales returns 49,000   $ 415,000
Advertising costs $ 10,000 $ 14,000  
Options to Purchase Common Shares [Member]      
Property, Plant and Equipment [Line Items]      
Antidilutive securities excluded from computation of earnings per share amount 25,982 265,250  
Warrants to Purchase Common Shares [Member]      
Property, Plant and Equipment [Line Items]      
Antidilutive securities excluded from computation of earnings per share amount 43,267 38,859  
Convertible Preferred Stock [Member]      
Property, Plant and Equipment [Line Items]      
Antidilutive securities excluded from computation of earnings per share amount 25,088,511 32,434  
Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property and equipment, useful life 5 years    
Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property and equipment, useful life 10 years    
v3.23.3
LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cash $ 49,517 $ 12,274
Working capital deficit 4,400,000  
Accumulated deficit $ 56,563,715 $ 55,368,868
v3.23.3
SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 342,403 $ 342,403
Accumulated depreciation (223,297) (201,517)
Property and equipment, net 119,106 140,886
Tooling And Testing Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 338,572 338,572
Furniture Fixtures And Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 3,831 $ 3,831
v3.23.3
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 21,780 $ 21,780
v3.23.3
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 387,284 $ 387,284
Accumulated amortization (257,843) (241,985)
Intangible assets, net 129,441 145,299
Trademarks 9,072 9,072
Total intangible assets 138,513 154,371
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 361,284 361,284
Patents [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 6 years  
Patents [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 20 years  
Proprietary Technology [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 13,000 13,000
Estimated Life 10 years  
Tradename and Brand [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 13,000 $ 13,000
Tradename and Brand [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 5 years  
Tradename and Brand [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Estimated Life 10 years  
v3.23.3
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Remaining in 2023 $ 15,858  
2024 31,716  
2025 24,652  
2026 16,032  
2027 16,032  
Thereafter 25,151  
Intangible assets, net $ 129,441 $ 145,299
v3.23.3
INTANGIBLE ASSETS (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 15,858 $ 48,458
v3.23.3
SCHEDULE OF LEASE COST (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Leases        
Operating lease cost $ 141,064 $ 288,134 $ 306,250 $ 575,804
Amortization of right-of-use assets 39,706 84,174
Interest on lease liabilities 6,785 14,097
Total lease cost $ 141,064 $ 334,625 $ 306,250 $ 674,075
v3.23.3
SCHEDULE OF OTHER INFORMATION RELATED TO LEASES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Leases        
Operating cash flows used for operating leases $ 217,500 $ 262,004 $ 463,424 $ 525,620
Financing cash flows used for financing leases 45,499 95,160
Assets obtained in exchange for operating lease liabilities
Assets obtained in exchange for finance lease liabilities
Weighted average remaining lease term: operating leases 7 years 7 months 6 days 8 years 7 months 6 days 7 years 7 months 6 days 8 years 7 months 6 days
Weighted average remaining lease term: finance leases 2 years 10 months 24 days 3 years 10 months 24 days 2 years 10 months 24 days 3 years 10 months 24 days
Weighted average discount rate: operating leases 5.60% 5.60% 5.60% 5.60%
Weighted average discount rate: finance leases 5.16% 5.16% 5.16% 5.16%
v3.23.3
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS REQUIRED UNDER OPERATING AND FINANCING LEASE OBLIGATIONS (Details)
Jun. 30, 2023
USD ($)
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]  
Operating Leases 2023 $ 585,927
Operating Leases 2024 955,272
Operating Leases 2025 870,000
Operating Leases 2026 870,000
Operating Leases 2027 870,000
Operating Leases Thereafter 2,682,500
Operating Leases, Undiscounted lease liabilities 6,833,699
Operating Leases Less: imputed interest (1,215,246)
Operating lease, Net lease liabilities 5,618,453
Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]  
Finance Leases 2023 139,080
Finance Leases 2024 139,080
Finance Leases 2025 139,080
Finance Leases 2026 68,395
Finance Leases 2027
Finance Leases Thereafter
Finance Leases, Undiscounted lease liabilities 485,635
Finance Leases Less: imputed interest (42,108)
Finance lease, Net lease liabilities 443,527
2023 725,007
2024 1,094,352
2025 1,009,080
2026 938,395
2027 870,000
Thereafter 2,682,500
Undiscounted lease liabilities 7,319,334
Less: imputed interest $ (1,257,354)
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Operating lease, Net lease liabilities
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Finance lease, Net lease liabilities
Net lease liabilities $ 6,061,980
v3.23.3
LEASES (DISCONTINUED OPERATIONS) (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Lease expiration description These leases expire at various dates through 2031 and have monthly base rents which range from $800 to $81,000.  
Sublease income $ 14,000 $ 68,000
Minimum [Member]    
Monthly base rent 800  
Maximum [Member]    
Monthly base rent $ 81,000  
v3.23.3
SCHEDULE OF LONG - TERM DEBT (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
Shareholder, convertible and contingently convertible notes $ 309,500 $ 309,500
Accrued interest 34,793 26,763
Total shareholder notes and accrued interest 344,293 336,263
Less: current maturities (344,293) (336,263)
Total long-term debt
v3.23.3
SCHEDULE OF RELATED PARTY DEBT (Details) - USD ($)
Jun. 30, 2023
Jan. 06, 2023
Dec. 31, 2022
Short-Term Debt [Line Items]      
Long term debt, current   $ 80,000  
Accrued interest $ 28,177   $ 24,552
Related Party [Member]      
Short-Term Debt [Line Items]      
Due to related party 173,177   169,552
Less: current maturities (173,177)   (169,552)
Due to related party, noncurrent  
Rotman Family Convertible Notes [Member]      
Short-Term Debt [Line Items]      
Long term debt, current 5,000   5,000
Rotman Family Non Convertible Notes [Member]      
Short-Term Debt [Line Items]      
Long term debt, current $ 140,000   $ 140,000
v3.23.3
SCHEDULE OF NOTES PAYABLE (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jan. 06, 2023
Dec. 31, 2022
Aug. 17, 2021
Short-Term Debt [Line Items]        
Principal amount   $ 80,000    
Rotman Family Convertible Notes Five [Member] | Jamie Rotman [Member]        
Short-Term Debt [Line Items]        
Bernard Rotman 5.00% note due July 2023 $ 5,469   $ 5,344  
Issue date Aug. 17, 2021      
Principal amount $ 5,000     $ 5,000
Rotman Family Non-convertible Notes One [Member] | Bernard Rotman [Member]        
Short-Term Debt [Line Items]        
Bernard Rotman 5.00% note due July 2023 $ 167,708   $ 164,208  
Issue date Jul. 18, 2019      
Principal amount $ 140,000      
v3.23.3
SCHEDULE OF NOTES PAYABLE (Details) (Parenthetical)
6 Months Ended
Jun. 30, 2023
Aug. 17, 2021
Rotman Family Convertible Notes Five [Member]    
Short-Term Debt [Line Items]    
Interest rate   5.00%
Rotman Family Convertible Notes Five [Member] | Jamie Rotman [Member]    
Short-Term Debt [Line Items]    
Interest rate 5.00%  
Due date 2023-08  
Rotman Family Non-convertible Notes One [Member] | Bernard Rotman [Member]    
Short-Term Debt [Line Items]    
Interest rate 5.00%  
Due date 2023-07  
v3.23.3
NOTES PAYABLE AND LOAN FACILITY (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Aug. 17, 2021
Apr. 30, 2022
Jun. 30, 2023
Dec. 31, 2018
Jan. 06, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
May 29, 2020
Line of Credit Facility [Line Items]                  
Debt face amount         $ 80,000        
Blue Oar Consulting, Inc. [Member]                  
Line of Credit Facility [Line Items]                  
Interest rate   6.00%              
Proceeds from related party   $ 500,000              
Debt frequency of periodic payment   weekly              
Debt periodic payments   $ 12,500              
Convertible Promissory Notes [Member]                  
Line of Credit Facility [Line Items]                  
Debt face amount             $ 290,000    
Discount rate             5.00%    
Conversion price             $ 1.60    
Debt description     two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18.            
Debt beneficial conversion feature     $ 90,000            
Contingently Convertible Notes Payable [Member]                  
Line of Credit Facility [Line Items]                  
Discount rate       5.00%       8.00%  
Maturity date       The note matured one year from issuance and was extended one (1) additional year by the Company.          
Debt closing discount rate, percentage       50.00%          
Debt, outstanding amount     19,500     $ 19,500      
Rotman Family Convertible Notes Five [Member]                  
Line of Credit Facility [Line Items]                  
Conversion price $ 1.60                
Debt description two conversion prices of $0.15 and $2, which equates to a blended conversion price of $0.18.                
Debt beneficial conversion feature $ 2,000                
Interest rate 5.00%                
Rotman Family Non-convertible Notes One [Member]                  
Line of Credit Facility [Line Items]                  
Notes payable with accrued interest     $ 168,000     164,000      
Rotman Family Non-convertible Notes One [Member] | Rotmans [Member]                  
Line of Credit Facility [Line Items]                  
Acquisition percentage     58.00%            
Related Party [Member]                  
Line of Credit Facility [Line Items]                  
Due from related parties     $ 187,342     1,853,972      
Due to related parties     $ 173,177     169,552      
Related Party [Member] | Blue Oar Consulting, Inc. [Member]                  
Line of Credit Facility [Line Items]                  
Due to related parties   $ 100,000              
Bernard Rotman [Member] | Rotman Family Non-convertible Notes One [Member]                  
Line of Credit Facility [Line Items]                  
Maturity date     December 2023            
Interest rate     5.00%            
Notes payable with accrued interest     $ 140,000            
Repayments of convertible debt     2,917            
Other Vendors [Member] | Fidelity Bank [Member]                  
Line of Credit Facility [Line Items]                  
Fair value of amount outstanding                 $ 2,300,000
Jamie Rotman [Member] | Rotman Family Convertible Notes Five [Member]                  
Line of Credit Facility [Line Items]                  
Debt face amount $ 5,000   5,000            
Debt, outstanding amount     $ 5,469     5,344      
Interest rate     5.00%            
Notes payable with accrued interest     $ 5,000     5,000      
Blue Oar Consulting [Member]                  
Line of Credit Facility [Line Items]                  
Notes payable with accrued interest     $ 22,518     $ 407,000      
v3.23.3
SCHEDULE OF ACTIVITY OF STOCK SUBSCRIPTION PAYABLE (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
Stock subscription payable, Beginning balance $ 1,655,208 $ 1,247,549
Stock subscription payable shares, Beginning balance 2,131,876 605,058
Stock subscription payable, Additions $ 246,114 $ 659,647
Stock subscription payable shares, Additions 3,455,456 1,552,386
Stock subscription payable, Issuances   $ (251,988)
Stock subscription payable shares, Issuances   (25,568)
Stock subscription payable, Ending balance $ 1,901,322 $ 1,655,208
Stock subscription payable shares, Ending balance 5,587,332 2,131,876
v3.23.3
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jul. 08, 2022
Apr. 11, 2022
May 02, 2013
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2021
Class of Stock [Line Items]              
Stock subscription payable       $ 1,901,322 $ 1,655,208   $ 1,247,549
Stock Subscription Agreement [Member]              
Class of Stock [Line Items]              
Common stock subscription received       $ 270,000 $ 270,000    
Common stock issued for settlement of related party payable, shares           180,000  
10% Series A Cumulative Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Number of shares issued in transaction     200,000        
Sale of stock price per share     $ 10        
Sale of stock consideration received on transaction     $ 2,000,000        
Preferred stock conversion price     $ 7.50        
Convertible conversion price     $ 5.00        
Additional number of shares invested value     $ 25,000        
Preferred stock dividend     $ 10        
10% Series A Cumulative Convertible Preferred Stock [Member] | Holder [Member]              
Class of Stock [Line Items]              
Preferred stock, shares outstanding       8,698 8,698    
Preferred stock, undeclared dividends       $ 88,000 $ 83,000    
Conversion of stock. shares       34,135 33,292    
10% Series A Cumulative Convertible Preferred Stock [Member] | Private Placement [Member]              
Class of Stock [Line Items]              
Number of shares issued in transaction     200,000        
10% Series A Cumulative Convertible Preferred Stock [Member] | Series A Cumulative Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Cumulative convertible preferred stock, dividend rate     10.00%        
10% Series A Cumulative Convertible Preferred Stock [Member] | Series B Cumulative Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Cumulative convertible preferred stock, dividend rate   10.00%          
10% Series A Cumulative Convertible Preferred Stock [Member] | Series C Cumulative Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Cumulative convertible preferred stock, dividend rate 10.00%            
Series A Preferred Stock [Member]              
Class of Stock [Line Items]              
Convertible preferred stock, liquidation preference       $ 175,000 $ 170,000    
Preferred stock, shares outstanding       8,698 8,698    
Preferred stock, shares authorized       15,000,000 15,000,000    
10% Series B Cumulative Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Cumulative convertible preferred stock, dividend rate   10.00%          
Preferred stock dividend   $ 7          
Conversion of stock. shares   1,000          
Preferred stock, shares authorized   2,500,000          
10% Series B Cumulative Convertible Preferred Stock [Member] | Holder [Member]              
Class of Stock [Line Items]              
Preferred stock, shares outstanding       370,969 370,969    
Preferred stock, undeclared dividends       $ 242,000 $ 108,000    
Conversion of stock. shares       4,055,250 3,864,261    
Series B Preferred Stock [Member]              
Class of Stock [Line Items]              
Convertible preferred stock, liquidation preference       $ 2,839,000 $ 2,710,000    
Preferred stock, shares outstanding       370,969 370,969    
Preferred stock, shares authorized       2,500,000 2,500,000    
10% Series C Cumulative Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Cumulative convertible preferred stock, dividend rate 10.00%            
Preferred stock dividend $ 2.61            
Conversion of stock. shares 1,000            
Preferred stock, shares authorized 2,500,000            
10% Series C Cumulative Convertible Preferred Stock [Member] | Holder [Member]              
Class of Stock [Line Items]              
Preferred stock, shares outstanding       1,917,973 1,917,973    
Preferred stock, undeclared dividends       $ 475,000 $ 325,000    
Conversion of stock. shares       20,999,125 20,425,550    
Series C Preferred Stock [Member]              
Class of Stock [Line Items]              
Convertible preferred stock, liquidation preference       $ 5,481,000 $ 5,233,000    
Preferred stock, shares outstanding       1,917,973 1,917,973    
Preferred stock, shares authorized       2,500,000 2,500,000    
v3.23.3
SCHEDULE OF REVENUES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Net sales $ 36,126 $ 45,323 $ 446,033 $ 168,843
Net sales, percentage 100.00% 100.00% 100.00% 100.00%
Air Purification Units [Member]        
Disaggregation of Revenue [Line Items]        
Net sales $ 20,169 $ 38,941 $ 423,865 $ 142,231
Net sales, percentage 55.80% 85.90% 95.00% 84.20%
Mattresses and Toppers [Member]        
Disaggregation of Revenue [Line Items]        
Net sales $ 13,895 $ 5,126 $ 19,906 $ 17,640
Net sales, percentage 38.50% 11.30% 4.50% 10.50%
Other [Member]        
Disaggregation of Revenue [Line Items]        
Net sales $ 2,062 $ 1,256 $ 2,262 $ 8,972
Net sales, percentage 5.70% 2.80% 0.50% 5.30%
v3.23.3
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of Shares, Outstanding, Granted 0 0  
Stock Options [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of Shares, Outstanding, Beginning balance 265,267    
Weighted Average Exercise Price, Outstanding, Beginning balance $ 19.54    
Weighted Average Remaining Contractual Life, Outstanding 11 months 15 days   6 months 3 days
Number of Shares, Outstanding, Granted    
Number of Shares, Outstanding, Exercised    
Number of Shares, Forfeited (222,000)    
Weighted Average Exercise Price, Forfeited $ 21.95    
Number of Shares, Outstanding, Ending balance 43,267   265,267
Weighted Average Exercise Price, Outstanding, Ending balance $ 7.16   $ 19.54
Number of Shares, Exercisable, Ending balance 43,267    
Weighted Average Exercise Price, Exercisable, Ending balance $ 7.16    
Weighted Average Remaining Contractual Life, Exercisable 11 months 15 days    
v3.23.3
SCHEDULE OF WARRANT ACTIVITY (Details) - Stock Warrants [Member] - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Outstanding, Beginning balance 37,266  
Weighted Average Fair Value, Outstanding, Beginning balance  
Weighted Average Exercise Price, Outstanding, Beginning balance $ 7.57  
Weighted Average Remaining Contractual Life, Outstanding 1 year 4 months 6 days 1 year 3 months 21 days
Number of Shares, Granted  
Weighted Average Fair Value, Granted  
Number of Shares, Exercised  
Weighted Average Fair Value, Exercised  
Number of Shares, Forfeited  
Weighted Average Fair Value, Forfeited  
Number of Shares, Expired (11,284)  
Weighted Average Fair Value, Expired  
Weighted Average Exercise Price, Expired $ 32.22  
Number of Shares, Outstanding, Ending balance 25,982 37,266
Weighted Average Fair Value, Outstanding, Ending balance
Weighted Average Exercise Price, Outstanding, Ending balance $ 6.57 $ 7.57
Number of Shares, Exercisable, Ending balance 25,982  
Weighted Average Fair Value, Exercisable, Ending balance  
Weighted Average Exercise Price, Exercisable, Ending balance $ 6.57  
Weighted Average Remaining Contractual Life, Exercisable 1 year 4 months 6 days  
v3.23.3
SHARE-BASED COMPENSATION (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2009
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2004
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock-based compensation       $ 246,114 $ 476,805    
Accrued share-based compensation       $ 1,631,322   $ 1,385,208  
Expected dividend yield rate       0.00%      
Share-based compensation   $ 107,204 $ 338,857 $ 246,114 $ 476,805    
Unrecognized compensation expenses   $ 0   $ 0      
Number of options granted       0 0    
Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Shares to be issued             40,000
Share based arrangement additional authorized shares 100,000            
Number of shares available for issuance   22,518   22,518      
Share based arrangement vested period       4 years      
Share based arrangement exercisable period       10 years      
Stock Option Plan [Member] | 2014 [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based arrangement additional authorized shares       50,000      
Stock Option Plan [Member] | 2019 [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based arrangement additional authorized shares       500,000      
Employee and Board Members [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share-based compensation         $ 7,682    
v3.23.3
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
6 Months Ended
Jul. 22, 2019
Jun. 30, 2023
Dec. 31, 2022
Related Party Transaction [Line Items]      
Stock subscription payable   $ 730,954  
Stock subscription payable, shares   2,491,000  
Reimbursable expenses payable   $ 213,155  
Employee-related liabilities   116,403  
Designcenters [Member]      
Related Party Transaction [Line Items]      
Stock subscription payable   $ 42,000  
Stock subscription payable, shares   8,500  
Blue Oar Consulting, Inc. [Member]      
Related Party Transaction [Line Items]      
Payment made by shares   $ 12,500  
Debt instrument, interest rate, effective percentage   50.00%  
Related party expenses   $ 224,000  
Stock subscription payable   $ 764,147  
Stock subscription payable, shares   2,934,000  
Steven Rotman [Member]      
Related Party Transaction [Line Items]      
Common Stock, Shares Subscribed but Unissued   100,000 20,000
Common Stock, Value, Subscriptions   $ 291,000 $ 58,200
Related party advances   30,225  
Gregory Rotman [Member]      
Related Party Transaction [Line Items]      
Related party advances   269,659  
Per Month [Member] | Blue Oar Consulting, Inc. [Member]      
Related Party Transaction [Line Items]      
Related party paid in cash   15,000  
Per Steven Rotman Employment Agreement [Member]      
Related Party Transaction [Line Items]      
Related party paid in cash $ 5,000    
Payment made by shares $ 10,417    
Debt instrument, interest rate, effective percentage 50.00%    
Related party expenses   $ 210,000  
Per Steven Rotman Employment Agreement [Member] | Per Year [Member]      
Related Party Transaction [Line Items]      
Related party paid in cash $ 125,000    
v3.23.3
COMMITMENTS (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Jan. 06, 2023
Commitments and Contingencies Disclosure [Abstract]    
Damages paid value $ 1,820,000  
Settlement interest 24.00%  
Conversion of stock shares converted 36,575,555  
Contingency receivable $ 4,802,000  
Settlement interest 24.00%  
Long term debt, current   $ 80,000
v3.23.3
MAJOR CUSTOMERS AND VENDORS (Details Narrative) - Supplier Concentration Risk [Member] - One Major Vendor [Member] - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Sales [Member]    
Concentration Risk [Line Items]    
Concentration of risk, percentage 21.00%  
Accounts payable $ 1,429  
Purchase [Member]    
Concentration Risk [Line Items]    
Concentration of risk, percentage   16.00%
Accounts payable   $ 81,000
v3.23.3
SCHEDULE OF PROVISION FOR INCOME TAXES (Details)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]    
Federal statutory income tax rate (21.00%) (21.00%)
Change in valuation allowance on net operating loss carryforwards 21.00% 21.00%
Effective income tax rate 0.00% 0.00%
v3.23.3
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]    
NOL carryforwards $ 8,350,000 $ 8,300,000
Less valuation allowance (8,350,000) (8,300,000)
Deferred tax assets
v3.23.3
INCOME TAXES (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Loss Carryforwards [Line Items]    
Federal statutory income tax rate 21.00% 21.00%
Deferred tax operating loss carryforward $ 8,350,000 $ 8,300,000
Georgia [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred tax operating loss carryforward 18,400,000  
Massachusetts [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred tax operating loss carryforward 21,200,000  
Expires Beginning in 2024 [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred tax operating loss carryforward 18,400,000  
Carried Forward Indefinitely [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred tax operating loss carryforward 21,400,000  
Domestic Tax Authority [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred tax operating loss carryforward 39,800,000  
Net operating loss carryforward 5,500,000  
Domestic Tax Authority [Member] | Carried Forward Indefinitely [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carryforward 3,700,000  
Domestic Tax Authority [Member] | Expires Beginning In 2029 [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carryforward 1,800,000  
State and Local Jurisdiction [Member] | Expired Beginning In 2038 [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carryforward $ 4,600,000  
Tax Year 2020 [Member]    
Operating Loss Carryforwards [Line Items]    
Enacted taxable income 80.00%  
v3.23.3
SCHEDULE OF DISCONTINUED OPERATIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]          
Revenue $ 50,000 $ 3,150,710 $ 157,479 $ 6,866,448  
Cost of revenue 1,442,022 122,650 3,064,071  
Gross profit 50,000 1,708,688 34,829 3,802,377  
Salaries, wages and benefits 101,954 726,436 366,625 1,575,580  
Agent fees 327,007 745,186  
Professional fees 23,099 111,326 121,692 167,916  
Advertising (824) 306,103 66,456 593,357  
Rent 181,061 177,184 360,843 352,518  
Service charges 319 82,635 20,919 188,038  
Depreciation and amortization 4,640 115,461 9,824 230,922  
Other operating 124,733 367,469 651,238 820,797  
Total operating expenses 434,982 2,213,621 1,597,597 4,674,314  
Loss from operations (384,982) (504,933) (1,562,768) (871,937)  
Interest expense (76,737) (95,688) (160,439) (190,282)  
Gain on settlement of debt, net 39,770  
Gain on sale of property and equipment 213,776 213,776  
Other income 26,594 33,752 32,290 67,704  
Total other income (expense), net 163,633 (61,936) 125,397 (122,578)  
Current assets:          
Cash 131,112 123,325 131,112 123,325  
Accounts receivable 187,342 1,853,972 187,342 1,853,972  
Other receivables 33,334 684,775 33,334 684,775  
Inventories 76,379 76,379  
Prepaid expenses and other 399,616 288,520 399,616 288,520  
Total current assets 751,404 3,026,971 751,404 3,026,971  
Non-current assets:          
Property and equipment, net 114,889 490,420 114,889 490,420  
Operating lease right-of-use assets, net 6,642,285 7,008,276 6,642,285 7,008,276  
Other assets 5,274 5,274 5,274 5,274  
Total non-current assets 6,762,448 7,503,970 6,762,448 7,503,970  
Current liabilities:          
Accounts payable 254,937 339,426 254,937 339,426  
Accrued expenses 125,525 726,410 125,525 726,410  
Operating lease liabilities - current maturities 811,000 737,000 811,000 737,000  
Finance lease liabilities - current maturities 181,000 119,000 181,000 119,000  
Related party debt - current maturities 22,518 406,753 22,518 406,753  
Total current liabilities 1,394,980 2,328,589 1,394,980 2,328,589 $ 2,328,589
Non-current liabilities:          
Operating lease liabilities, net of current maturities 4,807,453 5,189,140 4,807,453 5,189,140  
Finance lease liabilities, net of current maturities 262,527 324,527 262,527 324,527  
Total non-current liabilities $ 5,069,980 $ 5,513,667 5,069,980 5,513,667 $ 5,513,667
Depreciation     9,824 106,756  
Bad debts     4,537 3,461  
Amortization of intangible assets     124,166  
Noncash lease expense     73,408 153,016  
Gain on settlement of debt, net     $ (39,770)  
v3.23.3
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]
1 Months Ended
Sep. 30, 2023
USD ($)
Subsequent Event [Line Items]  
Heating costs $ 9,833
Insurance costs 10,106
Monthly rent $ 30,993
Lease term 5 years

Vystar (CE) (USOTC:VYST)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Vystar (CE) Charts.
Vystar (CE) (USOTC:VYST)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Vystar (CE) Charts.